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ABSTRACT 
Despite the growing evidence that circulating sex hormones during puberty may help 
explain the subtle sex differences that exist in the symptom profile, neuropathology 
and clinical sequelae of ADHD, there is limited research in this area. The current 
study investigated how the timing of female pubertal maturation influences the extent 
of ADHD symptoms in a non-clinical female undergraduate sample (N=253). 
Participants completed a set of self-report rating scales examining pubertal onset, and 
ADHD symptoms and related deficits. Using logistic regression models, difficulties in 
attention, emotion regulation, psychosocial functioning and more risky behaviour 
were shown to significantly help classify those who reported having an earlier 
pubertal onset relative to their peers. That is, early puberty was associated with 
increased symptom endorsement on a variety of ADHD-related variables. Findings 
highlight the potential role of sex hormones during puberty in explaining the 
differences in gender prevalence rates of ADHD and symptom profiles. 
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CHAPTER I 
Introduction 
Attention deficit/hyperactivity disorder (ADHD) is a neurobehavioural 
developmental disorder typically diagnosed in childhood (APA, 2013; Miller, 2012). 
Although prevalence rates vary widely due to methodological issues (e.g., sampling 
techniques, diagnostic criteria), ADHD continues to be the most common childhood 
psychiatric diagnosis affecting approximately 5.5% of children worldwide (Polanczyk, de 
Lima, Horta, Biederman, & Rohde, 2007).  Over the last couple of decades, there has 
been increasing awareness that the symptoms observed in childhood often continue into 
adulthood, with many children with ADHD not “outgrowing” the disorder (Barkley, 
Fischer, Edelbrock, & Smallish, 1990; Kalbag & Levin, 2005; Halperin, Trampush, 
Miller, Marks, & Newcorn, 2008), although there is debate over the extent of symptom 
preservation (Hill & Schoener, 1996; Mannuzza et al., 1991). Nevertheless, data on 
prevalence rates in adolescence and adulthood are limited and likely echo both under-
diagnosis and lack of clinical attention given to this age range (Kalbag & Levin, 2005; 
Miller, 2012).  According to Fayyad and colleagues (2007), ADHD affects approximately 
3-4% of the adult population worldwide. Such a remarkable statistic supports the fact that 
adult ADHD requires more attention and needs to be studied more thoroughly. 
To receive an adult diagnosis of ADHD, several symptoms present before age 12 
must persist into adulthood (APA, 2013a). However, late adolescents and young adults 
with ADHD and their parents have limited recall of childhood ADHD symptoms, 
questioning the validity and use of such retrospective data when making a diagnosis 
(Barkley, Knouse, & Murphy, 2011; Miller, Newcorn, & Halperin, 2010). Relatedly, 
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there is a tendency for adults to not connect ADHD symptoms and associated 
impairments to adult ADHD if they were not diagnosed as children (Kalbag & Levin, 
2005), and rather to attribute them to personality or character traits (Barkley & Brown, 
2008). Finally, while it has been suggested that the symptoms required by the Diagnostic 
and Statistical Manual of Mental Disorders (DSM) may not be developmentally 
appropriate, the current DSM has not made changes to the diagnostic criteria to 
appropriately address the changes in developmental norms across the life span (APA, 
2013b; Barkley, Murphy, & Fischer, 2008; Miller, 2010). Gaps in our current 
understanding of adult ADHD, and poor consensus regarding what might constitute 
appropriate diagnostic criteria highlight the need for research investigating the 
persistence of this disorder into adulthood, with the goal of developing new criteria that 
incorporates symptoms more relevant to the challenges encountered by young adults. 
Across clinical settings ADHD is reported to be more common in males than in 
females, with male childhood rates approximately two times larger than females (APA, 
2013a). Notably, studies examining ADHD symptoms, including those based on 
university samples, overwhelmingly sample males (Biederman et al., 1993, as cited in 
Rodriguez & Span, 2008). Consequently, the manifestation of ADHD in females has 
been neglected in the literature, as have sex differences in ADHD (Arnold, 1996). It has 
been speculated that this paucity in the literature, in addition to sex differences in the 
outward display of ADHD symptoms, has led to the sex discrepancy in clinical referrals 
and sampling bias (Mahone, 2010; Sciutto, Nolfi, & Bluhm, 2004). For instance, even 
when the expression of ADHD symptoms is equal, teachers are still more likely to refer 
boys than girls for treatment (Sciutto et al., 2004). Whereas childhood prevalence rates 
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continuously suggest greater ADHD rates for males than females, there is some 
indication that the male bias in ADHD is eliminated by adulthood (DuPaul et al., 2001; 
Nussbaum, 2012).  Importantly, females with ADHD are equally susceptible to life 
course impairments as are males (Lee, Lahey, Owens, & Hinshaw, 2008), and may even 
be more prone to particular disorders (e.g., eating disorders; Biederman et al., 2010).  
Thus, this neglect is a public health concern affecting hundreds of thousands of affected 
females (Arnold, 1996).  
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CHAPTER II 
Review of Literature 
Organization of Review 
This chapter begins with a review of the relevant literature on attention deficit 
hyperactivity disorder (ADHD), followed by a discussion on human pubertal 
development. This is then followed by the presentation of literature supporting a link 
between female pubertal development and sex-specific ADHD symptom manifestation. 
Finally, an outline of the purpose of the proposed study and the research questions is 
given. 
Attention Deficit Hyperactivity Disorder 
The most current edition of the DSM (DSM-5) defines ADHD as a “persistent 
pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or 
development” (APA, 2013a, p. 59). The DSM-5, like the DSM-IV-TR, distinguishes four 
subtypes of ADHD: Combined type, Predominantly Inattentive, Predominantly 
Hyperactive-Impulsive, and Other Specified ADHD. The Combined type is the most 
common, accounting for 50-75% of diagnoses, and requires at least a total of six 
symptoms from both the hyperactive-impulsive and inattentive domains for diagnosis 
(APA, 2013a; Miller, 2012).  Notably, new to the DSM-5, the symptom threshold for 
those aged 17 and older has been lowered from six to five symptoms (APA, 2013a). 
Some symptoms indicative of an attention deficit are inability to ‘sustain attention’, 
‘easily distracted’ and ‘often forgetful’ (APA, 2013a). Examples of symptoms falling 
under the hyperactivity-impulsivity domain include, but are not limited to, ‘often fidgets’, 
‘runs about or climbs excessively in situations where inappropriate’, ‘talks excessively’, 
  5 
 
and has ‘difficulty awaiting turn’ (APA, 2013a).  Predominantly Inattentive and 
Predominantly Hyperactive-Impulsive subtypes account for 20-30% and less than 15% of 
diagnoses, respectively (Miller, 2012). The diagnosis of either subtype requires that the 
six symptoms (or five for older adolescents and adults) cluster within either the 
inattention or hyperactive-impulsive domains, although there may also be subclinical 
features present that would fall under the other category (APA, 2013a). Finally, the last 
subtype, Other Specified ADHD, is the subtype chosen when in the presence of 
significant impairment and distress there are prominent symptoms present yet they do not 
sufficiently meet all the criteria (APA, 2013a). Evident from the examples given above 
and in line with the criticism of the current DSM diagnostic criteria described above, this 
continues to be a very child-centric definition of ADHD. The DSM-5 committee 
attempted to remedy this by providing clinicians with examples of the types of 
behaviours that might manifest in older adolescents and adults with ADHD (APA, 
2013b). The manifestation of symptoms in adults is different, and characterized more by 
symptoms such as ‘racing thoughts’, ‘restlessness’, ‘making careless mistakes when work 
on a boring or difficult project’, ‘problems remembering appointments’, ‘feeling overly 
energetic and compelled to do things’, and ‘disrupting others when they are occupied’ 
(Barkley, 2011; Kessler, 2005).  It is important to note that whereas the use of these 
subtypes is common practice in North America, there is some indication that these 
subtypes are developmentally unstable (Lahey, Pelham, Loney, Lee, & Willcutt, 2005; 
Todd et al., 2008). Moreover, population-based behaviour genetic studies examining 
preferential familial clustering in the study of complex genetic traits, such as ADHD, 
suggest that ADHD is a single dimensional phenotype that varies in severity across 
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humans, and that when two dimensions are found, they are highly correlated (Acosta, 
Arcos-Burgos, & Muenke, 2004). Thus the utility of subtyping ADHD may be limited. 
ADHD has been predominantly conceptualized as a disorder of executive 
functioning, and thus commonly linked to a dysfunction of neural circuits in the 
prefrontal cortex (PFC) and the catecholamine neurotransmitter systems (Barkley, 1997; 
Halperin & Schulz, 2006; Nussbaum, 2012). In line with this conceptualization, children 
and adults with ADHD have shown impairment on a number of neuropsychological 
measures of executive function, including inhibitory control, self-regulation, planning, 
working memory, and shifting sets (Halperin & Schulz, 2006; Nussbaum, 2012).  To 
explain the executive functioning deficit present in ADHD, Barkley (2011d) 
conceptualizes the disorder as age-inappropriate behaviour in two domains of 
neuropsychological functioning that parallel the DSM subtypes categorization: 
Hyperactivity-Impulsivity (Inhibition) and Inattention (Meta-Cognition). Symptoms 
within the domain of hyperactivity-impulsivity reflect poor inhibition and are 
characterized by impairment in verbal and motor inhibition, impulsive decision making, 
inability to delay gratification, greater disregard for future consequences, excessive task-
irrelevant movement and emotional impulsiveness (Barkley, 1997; Barkley, 2011d; 
Brown, 2006).  Conversely, the ADHD deficit in attention is exemplified by impairment 
in resistance to responding to distraction, low persistence toward goals or tasks, poor 
working memory, difficulty re-engaging in a task following disruptions and poor 
emotional self-regulation (Barkley, 1997; Barkley, 2011d; Brown, 2006). It is important 
to note that this conceptualization of ADHD has not been unequivocally supported. 
Halperin and Schulz (2006) proposed that ADHD is not due to dysfunction of the PFC, 
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but rather due to subcortical neural dysfunction present during early development. As 
such, symptom diminution is due to the degree which the developing PFC is able to 
compensate for early neural deficit via its descending regulatory influence on more 
caudal neural structures. Moreover, the delay aversion model (Sonuga-Barke et al., 1996) 
and the cognitive-energetic model of ADHD (Sergeant, 2005) provide alternative 
explanations for the symptoms and behaviours present in ADHD, with the former 
implicating dysfunction to the neurobiological system linking present behaviour and 
future reward/punishments, and the latter attributing the symptoms to dysregulation of 
arousal centers.   
The neuroimaging literature has implicated three primary neural circuits in 
ADHD: fronto-striatal, fronto-cerebellar and fronto-limbic (Barkley, 2011d; Nigg & 
Casey, 2005). Fronto-striatal functioning is thought to be important in the detection of 
unpredicted reward or novel functioning and is associated with difficulties in response 
suppression, ability to maintain concentration, working memory, planning, and 
organization (Barkley, 2011d; Nigg & Casey, 2005). Alerting to, monitoring, and 
detecting the mistiming of events is thought to rely on fronto-cerebellar circuitry, and is 
associated with problems with timing, motor coordination and ‘timeliness of 
behaviour’(Barkley, 2011d; Nigg & Casey, 2005). Finally, the fronto-limbic circuit has 
also been implicated in ADHD, and is thought to underlie the detection and evaluation of 
emotionally significant events or situations and reinforcement learning. In turn, this 
circuit has been associated with the following symptoms: hyperactivity-impulsivity, 
emotional impulsivity, motivational difficulties, and propensity to aggression (Barkley, 
2011d; Nigg & Casey, 2005). These circuits are important in basic learning that forms the 
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foundation for behavioural, cognitive and emotional control, as well as adjusting to 
changes in the environment (Nigg & Casey, 2005). There is also recent evidence showing 
that the trajectory of early abnormal brain development within ADHD is sex dependent. 
For example, 4.5 and 8 year old boys with ADHD have less right-lateralized frontal alpha 
asymmetry than typically developing boys, whereas girls with ADHD show a more right-
lateralized asymmetry pattern than typically developing age-mates (Mahone & Wodka, 
2008).  Similarly, Hermens and colleagues (2005, as cited in Mahone & Wodka, 2008) 
showed that irrespective of ADHD subtype, female adolescents with ADHD have focal 
frontal increase in theta and electrodermal activity, while male adolescents with ADHD 
show a widespread increase in theta activity. Whereas certain circuits have been 
hypothesized to be impaired in ADHD, and neural abnormalities have been reported, it is 
noteworthy to remember that there is no neuroanatomical profile that is consistent across 
all individuals with ADHD (Miller, 2012). 
As previously mentioned, DSM-5 criteria continue to fail to account for the 
developmental changes in symptoms over time, although examples more appropriate for 
older ages have been provided (APA, 2013a). This limits the identification of many 
adolescents and adults who have ongoing and significant impairment due to ADHD 
despite not meeting full diagnostic criteria for the disorder (Miller, 2012). This has also 
been used to explain the lower persistance rates of the disorder into late adolescence and 
adulthood (Barkley, Murphy, & Fischer, 2008). Relatedly, a common diagnostic issue is 
whether the presence of less than the required number of symptoms warrants clinical 
attention (Kalbag & Levin, 2005). The current polythetic model of ADHD, in which 
various combinations of at least six symptoms are required for diagnosis, implies that 
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ADHD symptoms form a continuum rather than marking a categorical boundary between 
having and not having the disorder (Lubke et al., 2009). Moreover, for the symptoms to 
be diagnostic of ADHD they have to be developmentally inappropriate and result in 
impairment in major life activities (Barkley, Murphy & Fischer, 2008). By extension, 
given that the ADHD symptoms reflect extremes on the developmental continuum that 
are maladaptive and inconsistent with development level, it is possible to categorize all 
individuals somewhere on this spectrum. That is, some have suggested that ADHD 
reflects “an extreme on the quantiative manifestation of normal behaviour” (Acosta et al., 
2004, p. 3) allowing for the investigation of ADHD symptoms in a nonclinical sample. 
Past research has examined the severity of ADHD symptoms in clinical (e.g., Barkley et 
al., 2006) and nonclinical (e.g., Rodriguez & Span, 2008) samples, with more severe 
symptoms of ADHD being positively correlated with impairment in daily life activities 
and drinking habits, respectively.  
 Presently, there are no differences in recommendations for ADHD with respect to 
diagnostic cut points according to the sex of the individual as per the DSM-5 (APA, 
2013a). Further, the current set of symptoms neglects to mention certain central features 
of ADHD, such as emotional impulsiveness, poor emotional self-regulation, and poor 
working memory.  Applying results from the UMass study of clinic-referred adults with 
ADHD, Barkley, Fischer and Murphy (2008) encourage the use of nine symptoms based 
largely on the construct of impulse control and attention in identifying adults with 
ADHD, rather than the DSM-5 symptom list. Examples from this alternative list of 
symptoms are: ‘often have poor follow through on promises or commitments I make to 
others’, ‘start a project or task without reading or listening to instructions’ and ‘often 
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have difficulty performing things in proper order’ (Barkley et al., 2008). Finally, the 
current cutoffs and pattern of symptoms reflect research conducted mainly on males, and 
thus may need to be adjusted accordingly to reflect female-specific symptom profiles 
(Nadeau & Quinn, 2002; Rasmussen & Levander, 2009). A meta-analysis conducted by 
Gaube and Carlson (1997) suggested that women have a different pattern of symptoms, 
more dominated by inattention and less by hyperactivity, and present with higher rates of 
internalizing symptoms (e.g., mood and anxiety problems) than externalizing symptoms 
(e.g., conduct disorder) that are more common in males.  Applying Barkley’s broadband 
domains, meta-cognitive symptoms linked to dysfunction within the inattention domain 
(e.g., emotional self-regulation, planning/problem solving, and working memory) may be 
more affected in females with ADHD. Exemplifying the potential sex inappropriateness 
of current diagnostic criteria, females are more likely to have greater impairment than 
average when assessed using behaviour ratings of ADHD symptoms and yet not meet the 
diagnostic threshold (Waschbusch & King, 2006, as cited in Mahone, 2010). Thus, the 
relative neglect of incorporating these symptoms in the diagnosis of ADHD might 
explain the sex differences in prevalence. Notably, some studies do not report these sex 
discrepancies in the prevalence of ADHD inattention and hyperactivity/ impulsivity 
symptoms (Biederman, Faraone, Monuteaux, Bober, & Cadogen, 2004; Rasmussen & 
Levander, 2009), although their results may be due to sampling bias inherent in studies 
utilizing self-referral/treatment-seeking individuals.  Further, whereas Biederman and 
colleagues (2004) report similar phenotypic features in both males and females with 
ADHD, they do highlight that females with ADHD had significantly higher inattentive 
scores than their male counterparts. In line with this finding, Fedele and colleagues 
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(2012) report that college-aged ADHD females significantly endorse greater number of 
inattentive and hyperactive symptoms than college males with ADHD. Moreover, they 
show that even after controlling for symptom severity, emerging adult females with 
ADHD report having greater levels of impairment.  
Human Pubertal Development 
The lack of a clear and consistent pattern of results across studies examining 
symptom, behaviour, neuropsychological and neuroanatomical profiles of individuals 
with ADHD can at least partly be attributed to developmental factors (Halperin & Schulz, 
2006; Mahone, 2010). Adolescence marks a major developmental milestone, involving 
dramatic changes in physical, psychological, and social maturity (Paus, Keshavan, & 
Giedd, 2008). These developmental changes make adolescence a “period of vulnerability 
and adjustment” (Casey, Jones, & Hare, 2008, p. 111). Reflecting this vulnerability, this 
developmental period is a time of increased prevalence of several psychiatric illnesses 
(e.g., mood disorders and eating disorders; Paus et al., 2008), and risky behaviours (e.g., 
drug and alcohol use and unprotected sex; Casey & Jones, 2010). Fundamental to the 
changes occurring in adolescence are sex specific effects presumed to be caused, at least 
in part, by the increase in secretion of circulating sex steroids with the onset of puberty 
(Cahill, 2006).   
  Puberty, functionally coupled with adolescence, is defined as a period of elevated 
secretion of gonadal steroid hormones. The onset of puberty marks the start of a 
‘sensitive period’ in the development of and changes to the structural organization of the 
nervous system (Sisk & Zehr, 2005; Zehr, Culbert, Sisk & Klump, 2005;). In humans, 
pubertal maturation begins with hypothalamic gonadotropin releasing hormone (GnRH) 
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secretion, which activates the hypothalamic-pituitary-gonadal (HPG) axis (Palmert & 
Boepple, 2001; Sisk & Zehr, 2005). This period is “characterized by a gradual increase in 
the frequency and amplitude of intermittent episodes of GnRH release” (Sisk & Zehr, 
2005, p. 164). In turn, GnRH stimulates the production and secretion of luteinizing 
hormone (LH) and follicle stimulating hormone (FSH), pituitary gonadotropins, which 
promote release of sex steroid hormones (i.e., estradiol in females and testosterone in 
males), and completion of gamete development (i.e., egg and sperm; Sisk & Foster, 2004; 
Sisk & Zehr, 2005). The higher levels of estrogen and androgen in turn, trigger the 
development of secondary sex characteristics (e.g., breast development in females and 
growth of facial hair in males; Sisk & Zehr, 2005). It is important to remember that while 
a hallmark of puberty is the production and secretion of gonadal steroids, puberty is not 
only a gonadal event (Sisk & Zehr, 2005). Rather, it should be viewed as a “brain event”; 
a period when sex hormones interact with the developing adolescent nervous system 
(Sisk & Zehr, 2005, p. 164). In fact, puberty-related changes continue into the third 
decade of life, thus corresponding to the lengthy maturation of the brain, in particular of 
the frontal cortex that continues to develop well into the twenties (Gogtay et al., 2004; 
Sisk & Zehr, 2005). Relatedly, the nervous system has a reciprocal influence on gonadal 
development and maturation (Sisk & Zehr, 2005).  
The developing adolescent brain is highly receptive to the effects of gonadal 
steroid hormones. Circulating steroids (e.g., estradiol and progesterone) act in a time-
sensitive and graded manner to shape adolescent brain development during a protracted 
process that spans more than a decade (Sisk & Zehr, 2005; Zehr et al., 2007). This 
process is highly individualized. As such, variation in the age of puberty onset 
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contributes to individual differences in developmental course and behavioral maturation 
(Sisk & Zehr, 2005). Relatedly, differences in the timing of puberty will contribute to the 
diversity of adult psychological characteristics, behaviours, and relative risks for 
psychopathology (Sisk & Zehr, 2005; Zehr et al., 2007).  Finally, given the permanent 
organizational influence of gonadal hormones, effects dependent on the timing of puberty 
are likely to be permanent and observable in adulthood (Sisk & Zehr, 2005; Zehr et al., 
2007).   
The start of puberty in females is defined by the appearance of breast 
development, with a median age of onset of 10.0 years (Papadimitriou et al., 2008; Parent 
et al., 2003). Yet most studies examining the effects of timing of puberty onset typically 
use age at menarche as the marker of puberty onset, which has a median age of onset of 
12.5 years (Dorn & Biro, 2011; Parent et al., 2003). Although the physiology of puberty 
is common to all individuals, its onset occurs across a wide range of ages in the normal 
population (i.e., 11 years or earlier to 14 years or older; Palmert & Boepple, 2001; Parent 
et al., 2003).  Several pathologic conditions, such as central nervous system tumors or 
systemic illnesses, can influence timing of puberty (Palmert & Boepple, 2001). 
Moreover, the decrease in the age of pubertal onset over recent decades had been 
attributed to changes in family structure (e.g., father absence), better nutrition, increased 
obesity in childhood, and reductions in levels of childhood illness (DiVall & Radovick, 
2009; Downing & Bellis, 2009). Yet, most variation in pubertal timing has no known 
etiology, and much of this variation stems from differences in the reactivation of the HPG 
axis (Dorn & Biro, 2011; Parent et al., 2003). 
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Variation in sex steroid exposure has been used to explain sex differences in 
neuroanatomy and cognitive function (Sisk & Zehr, 2005).  For instance, it has been 
reported that females undergo an earlier peak in brain volume (Lenroot et al., 2007), 
greater growth in some structures over males (e.g., hippocampus; Sisk & Zehr, 2005), 
and less white matter growth than males during adolescence (Lenroot et al., 2007; Perrin 
et al., 2008). Given that circulating sex hormones influence virtually all mechanisms 
involved in the remodeling of the adolescent brain (e.g., dendritic elaboration, synaptic 
pruning, and axonal sprouting), it is not surprising that estrogen also plays a role in 
modulating cognition in the developing human brain (Sisk & Zehr, 2005). Relevantly, 
typical behavioural and cognitive changes noted in adolescence, such as risk-taking, 
reward sensitivity, sensation/novelty seeking, and basic cognitive abilities have been 
linked to pubertal maturation (Casey et al., 2008). For example, imbalance with the 
frontolimbic circuitry has been used to account for the greater prevalence of risky 
behaviours among adolescents and young adults, with only subcortical structures being 
directly linked to pubertal maturation (Steinberg et al., 2008).  Whereas the cognitive 
functions most likely to be affected will be those linked to neuroanatomical areas with the 
highest concentration of estrogen receptors, the scientific community remains uncertain 
regarding the role of sex hormones in cognition. 
Attention Deficit/Hyperactivity Disorder and Female Pubertal Development 
As discussed above and in common with many neurodevelopmental disorders, the 
prevalence of ADHD differs in males and females. In addition to the limitations inherent 
in the DSM-5 nomenclature and proposed inadequacy of current rating scales in 
capturing symptom severity among females, this sex discrepancy may, in part, be driven 
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by hormonal influences. ADHD in females presents at a later onset and with more subtle 
clinical symptoms, often of the predominantly inattentive subtype (Keltner & Taylor, 
2002).  The direct assessment of subtype differences is essential when investigating the 
hormonal influences on ADHD symptom manifestation (Mahone, 2010). It has been 
suggested that while females may be protected to some extent from the symptoms of 
ADHD pre-puberty because of their earlier brain maturation, increased release of 
estrogen with puberty, and corresponding increase in dopamine receptors, may lead to a 
subsequent increase in ADHD symptoms (Fink, Rosie, Grace, & Quinn, 1996, as cited in 
Nussbaum, 2012; Keltner & Taylor, 2002). That is, deficits in cognitive control may be 
the result of the direct influence of sex hormones on the dopaminergic neural circuitry in 
the nucleus accumbens, striatum, and prefrontal cortex (Martel, Klump, Nigg, Breedlove, 
& Sisk, 2009). Animal models reveal female specific modulatory effects of estrogen and 
progesterone on dopamine in the striatum and nucleus accumbens (Xia & Becker, 1994, 
as cited in Martel et al., 2009). Similarly, higher levels of extracellular estrogen during 
the estrous cycle in female rats are accompanied by greater dopamine release in the 
striatum. It is also interesting to note that the amygdala, hippocampus, and orbital and 
medial prefrontal cortices, and the hypothalamic-pituitary-adrenal axis are targets of 
estradiol at puberty. Therefore, previous reports of remitting symptoms in ADHD into 
adolescence and young adulthood may be more reflective of the trajectory of male 
ADHD symptoms. Conversely, just when male symptoms begin to diminish, female 
symptoms begin to be more apparent and reported (Keltner & Taylor, 2002). Relatedly, it 
has been noted that increased hormonal fluctuations throughout the phases of the 
menstrual cycle are associated with increased symptomatology (Nadeau, Littman, & 
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Quinn, 2006). Further supporting the existence of a link between hormones, particularly 
estrogen, and ADHD in females is the existence of ADHD comorbidities known to be 
influenced by pubertal onset (e.g., eating disorders, anxiety, substance use and 
depression; Zehr et al., 2007). That is, given that the manifestation of many of the known 
common comorbidities in females with ADHD have been shown to be affected by 
pubertal timing (Bijlenga et al., 2011; Klump et al., 2012; Westling, Andrews, Hampson, 
& Peterson, 2008) it seems highly plausible that a correlation between pubertal onset and 
ADHD exists. Finally, similar to the imbalance noted within the frontolimbic circuitry 
used to account for the greater prevalence of risky behaviours among adolescents and 
young adults (Steinberg et al., 2008), it is likely that the neural circuits implicated in the 
inattentive symptoms and emotional dysregulation of ADHD (i.e., frontal-striatal and 
frontal-limbic circuits) would also be affected by the puberty-dependent imbalance in 
maturation between subcortical and cortical regions.  
The Present Study 
The literature reviewed above indicates that puberty is a key time for 
neuroanatomical changes and that circulating sex steroids likely play a significant role. 
Moreover, data suggest that circulating sex steroids modulate cognition, especially those 
cognitive functions that are underpinned by anatomical structures richest in estrogen 
receptors, such as the frontal cortex. The frontal lobes subserve various functions (e.g., 
affective regulation, attention/arousal, and impulse control), and the prefrontal area, 
particularly involved in executive function, has been chiefly implicated in ADHD 
(Nussbaum, 2012). There is growing evidence that subtle sex differences exist in the 
symptom profile, neuropathology and clinical sequelae of ADHD, and that hormonal 
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factors may play an important role in understanding ADHD in females. Yet, to date, there 
has been little research on this topic. The present study sought to address the current gaps 
in our understanding of how female pubertal maturation influences the extent of ADHD 
symptoms in a nonclinical female sample. This was primarily an exploratory study. 
Nevertheless, given the noted negative consequences of early puberty onset, such as 
disordered eating and anxiety (Zehr et al., 2007), sexual risk taking, substance use and 
anti-social behaviour (Downing & Bellis, 2009), it was predicted that aberrations from 
typical pubertal onset, specifically early maturation relative to peers, would be associated 
with elevated levels of ADHD symptoms, impairments in daily functioning, and 
difficulties in emotion regulation. The findings from the study were aimed to add to the 
general understanding of the relationship between puberty onset and executive 
functioning. Further, the study was designed to add to our understanding of ADHD 
prevalence rates among females, and the potential female-specific adolescent onset of 
presenting symptoms. 
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CHAPTER III 
Methods 
Design of Study 
 A quantitative, cross-sectional non-experimental design was used to examine the 
predictive value of constructs associated with ADHD (e.g., executive functioning) on the 
pubertal timing of typically developing female emerging adults. The study was 
exploratory in nature, with limited past research to guide hypothesis generation. That 
said, it was predicted that early pubertal onset would be associated with a greater number 
of ADHD symptoms and related impairments. 
Participants 
An invitation to participate in the study was sent via the existing participant pool 
system within the Department of Psychology at the University of Windsor. Participation 
was open to females aged 18 to 25 years within the pool.  There were no restrictions 
based on race, socio-economic status, marital status, or neighbourhood of residence. 
Individuals who reported being unable to read, speak or write in English were excluded 
from participation. Finally, individuals with a self-reported history of traumatic brain 
injury were also excluded. 
At the outset, an estimated required sample size was determined by a power 
analysis using the G-power program.  A thorough literature review did not reveal prior 
studies upon which a hypothesized effect size could be estimated. As such, a small effect 
size value of 0.20 – 0.25 was chosen for the power analysis (Cohen, 1988). An alpha 
level = 0.05, effect size = 0.20 to 0.25, power level = 0.80, and one covariate suggested a 
sample size range of 158 to 244 participants. Correspondingly, the aim was to recruit 
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approximately 200 participants, however, recruitment proved easier than expected and 
information from a total of 254 female students was collected. One case was removed 
from the analysis because the same participant completed the study at two different time-
points, for a final total of 253 participants.  
 The mean age of the total sample was 20.19 years (± SD = 1.69). As described in 
greater detail below, participants were grouped based on timing of pubertal onset: early 
(mean age ± SD = 20.58 ± 1.88), on-time (mean age ± SD = 20.09 ± 1.65) and late (mean 
age ± SD = 19.98 ± 1.52). The majority of the sample (65.2%) self-identified as 
Caucasian, with 9.88% Asian/Asian-descent, 9.09% African-Canadian/Black, 1.19% 
Hispanic/Latino, 0.39% Aboriginal and 13.8% mixed-race or other. 78.3% of the sample 
identified English as their primary language and 24.9% reported being able to speak 
another language. In terms of marital status, 59.3% reported that they were single, 37.2% 
were in a romantic relationship and 3.56% were married or cohabiting. In addition to 
their studies at the university, 64.0% of the sample reported that they were employed 
outside the home.  
Parental education level was used as a proxy for socioeconomic status (SES).  
Specifically, 69.9% of participants reported that their mothers completed more than 12 
years of formal education (range = 1 to 22 years of formal education). A similar rate was 
obtained for paternal education level, with 68.1% of participants reporting that their 
fathers completed some level of post-secondary education (range = 8 to 22 years of 
formal education). These rates are comparable to those reported by Statistics Canada in 
2007 for the city of Windsor (62.04% of the population completed some level of post-
secondary education; Statistics Canada, 2007). 
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With regards to disclosure of relevant medical history, two participants identified 
history of head injury accompanied with a loss of consciousness, seven participants 
disclosed history of seizures, six participants identified that they had a diagnosis of a 
learning disorder, and 15 participants reported having a current mental disorder (e.g., 
depression, anxiety). In an attempt to increase the generalizability of the findings, only 
information provided by individuals with a reported history of head injury was excluded 
from analysis, reducing the sample size to 251.  Finally, it should be noted that the 
pubertal onset groups, described in detail below, did not significantly differ on any of 
these demographic variables.  
Procedure 
Once the participants arrived at the testing session and following the informed 
consent process, they were asked to complete a series of questionnaires. They were 
reminded that the session would last approximately one hour and that they would receive 
one psychology course bonus point following the completion of the questionnaires.  If 
they agreed to continue, the following questionnaires were presented for completion: (1) 
demographics form, (2) Pubertal Development Scale-Retrospective Version, (3) Barkley 
Adult ADHD Rating Scale – IV (BAARS-IV), (4) Barkley Deficits in Executive 
Functioning Scale (BDEFS), (5) Difficulties in Emotion Regulation Scale (DERS); (6) 
Barkley Functional Impairment Scale (BFIS); (7) Risk-Taking Behavior questionnaire. 
The participants completed the questionnaires in randomized order.  
Measures 
Demographics questionnaire. Demographic information was collected via a 
form completed by all participants. The form requested general information about 
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identity, including date of birth, race/ethnicity, marital status, parental education and 
employment, handedness, height, weight, days since last menstrual period, in addition to 
information about the participants’ medical (including current contraceptive use), and 
developmental histories. Appendices contain copies of all questionnaires administered.  
Pubertal Development Scale – Retrospective Version (PDS-RV).  Participants 
were asked to retrospectively answer questions on pubertal development using a modified 
version of the Pubertal Development Scale (PDS) obtained from Dr. Cheryl Sisk at 
Michigan State University. The original version of the PDS was designed for use with 
adolescents to assess current pubertal development of a number of secondary sex 
characteristics. Dr. Sisk and colleagues revised the modified version of the PDS in order 
to assess timing of pubertal development in post-pubertal adults. Initially used with an 
undergraduate sample at a large Midwestern university, Sisk and colleagues (2007) report 
that the modified measure has good psychometric properties. Specifically, they reported 
good internal consistency (α = 0.80 in females; α = 0.84 in males) and excellent test-
retest reliability (r = 0.87 for females; r = 0.83 for males).  For most items, the 
participants were asked to recall the timing of pubertal development relative to their peers 
(i.e., “much earlier than others” (1), “somewhat earlier” (2), “about the same time” (3), 
“somewhat later” (4), “much later” (5), or “do not know”). For other items, the 
participants were asked to estimate the age at which an event occurred. The total PDS-
RV score was calculated by summing the scores from the following 6 items: “In general, 
do you think your development was any earlier or later than most other girls?”; “Do you 
think your first period was any earlier or later than most other girls?”; “Do you think your 
breasts developed any earlier or later than most other girls?”; “Would you say that your 
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growth in height was any earlier or later than other girls?”; “Would you say that your 
growth of body hair was any earlier or later than other girls?”; “Would you say your skin 
changed any earlier or later than other girls?” Smaller summed total scores reflected 
earlier pubertal timing. All other items on the scale were informational, and were 
included to exclude outliers or identify potential new covariates.  
The mean PDS-RV total score for all participants was calculated to be 17.26 (SD 
= 4.084), with the scores ranging from 6.00 to 29.0. The PDS-RV total score was also 
examined per pubertal onset group, with the early pubertal onset group having a mean 
score of 12.21 (SD = 1.966, range = 6.00 – 14.75), the on-time onset pubertal group 
having a mean score of 17.22 (SD = 1.314, range = 15.00 – 19.18), and the late onset 
pubertal group having a mean score of 22.74 (SD = 2.156, range = 19.89 – 29.00). 
Cronbach’s alpha was calculated as a measure of internal consistency. This analysis 
revealed a good alpha value of 0.81.   
Barkley Adult ADHD Rating Scale-IV (BAARS-IV; Barkley, 2011a). Designed 
with consideration of DSM-IV diagnostic criteria, the BAARS-IV is a self-report 
questionnaire in which the participants were asked to report their current ADHD 
symptoms. Specifically, with regards to the current symptoms interview, the participants 
were asked to indicate to what extent each item described their behavior during the past 
six months. The possible response for the questionnaire ranged from “Never/Rarely” (1) 
to “Very Often” (4). A total ADHD score and symptom count was calculated by adding 
up the scores for each item answered.  From the BAARS-IV – current symptoms 
questionnaire, 4 subscale totals were calculated related to the four recognized ADHD 
symptom dimensions: Inattention, Hyperactivity, Impulsivity, and Sluggish Cognitive 
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Tempo (SCT). The internal consistency, construct validity, discriminant validity and 
criterion validity are all reported to be satisfactory (Barkley, 2011a).  
Examination of the total scores for the BAARS-IV current symptoms questionnaire 
for all study participants revealed a mean total score of 27.24 (SD = 6.498, range = 18.0 – 
51.0), out of a possible maximum score of 108.  Relatedly, analyzing the scores 
independently for each pubertal onset group revealed that the early pubertal onset group 
had a mean total score of 28.28 (SD = 6.846, range = 19.0 – 50.0), the on-time pubertal 
onset group had a mean total score of 26.37 (SD = 5.860, range = 18.0 – 51.0), whereas 
the late pubertal onset group had a mean total score of 27.95 (SD = 7.229, range = 18.0 – 
49.0). Table 1 displays the mean, standard deviation and range of scores for each 
subscale separately per pubertal onset group. The internal consistency for all 27 items 
was excellent, with an alpha value of 0.90. Calculation of Cronbach’s alpha for the 
inattention, hyperactivity, impulsivity and sluggish cognitive tempo subscales revealed 
alpha values of 0.82, 0.59, 0.69, and 0.87, respectively.  
Barkley Deficits in Executive Functioning Scale (BDEFS; Barkley, 2011b). 
The BDEFS is an 89-item Likert-type rating scale designed to evaluate the variety  
of behavioural, emotional, and motivational symptoms linked to executive functioning 
deficits. More specifically, this self-report measure aims to capture self-regulation ability 
within five domains: Self-Management to Time, Self-Organization/Problem Solving, 
Self-Restraint (Inhibition), Self-Motivation and Self-Regulation of Emotion. 
Correspondingly, the scale provides a global measure of deficits in executive functioning, 
as well as subscale scores for each of the five domains. Individuals are asked to indicate 
how frequently they experienced each of the problems in the past six months, with 
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possible responses ranging from “Never or Rarely” (1) to “Very Often” (4). Developed 
for use in a variety of settings, including research, the measure has been shown to have 
satisfactory reliability and validity (Barkley, 2011b).  
The mean BDEFS total score for all participants was 148.90 (SD = 34.64, range = 
91 – 273), out a possible maximum total score of 356. Table 1 includes the score statistics 
for each BDEFS subscale for all participants and per pubertal onset group. Internal 
consistency for the total score was evaluated to be excellent, with an alpha value of 0.97. 
Relatedly, the Cronbach’s alpha values for each subscale were also evaluated to be 
satisfactory (Self-Management to Time = 0.94; Self-Organization/Problem = 0.94; Self-
Restraint = 0.85; Self-Motivation = 0.84; and Self-Regulation of Emotion = 0.92). 
Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004). The 
DERS is a self-report measure designed to evaluate clinically significant difficulties in 
emotion regulation. The measure was originally developed with a large undergraduate 
sample at the University of Massachusetts – Boston (Gratz & Roemer, 2004), and has 
since been used with substance abusers and other clinical populations (Gratz et al., 2008). 
Participants were asked questions reflecting difficulties in four domains of emotion 
regulation, including (1) awareness and understanding of emotions; (2) acceptance of 
emotions; (3) the ability to use goal-directed behaviour and control impulsive behaviour 
when having negative emotions, and (4) ability to use effective emotion regulation 
strategies. They were asked to indicate how often the items apply to them, with responses 
ranging from “almost never” (1) to “almost always” (5). The total DERS score was 
calculated by summing the scores for all 36 items, with possible scores ranging from 36 
to 180. Gratz and Roemer (2004) report preliminary findings suggesting that the DERS 
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has high internal consistency, good test-retest reliability, and adequate construct and 
predictive validity.  
The mean DERS total score for all study participants was 81.80 (SD = 21.98), with 
the scores ranging from 39.0 to 153.0. Please refer to Table 1 for the mean, standard 
deviation and ranges for the score breakdown per pubertal onset group and per DERS 
subscale. The internal consistency for all 36 items of the DERS was excellent, with an 
alpha value of 0.94. Cronbach’s alphas were also calculated for each DERS subscale, 
revealing the following: Nonacceptance of Emotional Responses subscale (α = 0.89), 
Difficulties Engaging in Goal-Directed Behaviour subscale (α = 0.91), Impulse Control 
Difficulties (α = 0.88), Lack of Emotional Awareness (α = 0.84), Limited Access to 
Emotion Regulation Strategies (α = 0.89), and Lack of Emotional Clarity (α = 0.82).  
Barkley Functional Impairment Scale (BFIS; Barkley, 2011c). The BFIS is a 
self-report measure that was used to ask participants to rate the degree of psychosocial 
impairment they believe they are experiencing in 15 major domains of adult life activities 
(i.e., home-family, home-chores, work, social- strangers, social-friends, community 
activities, education, marriage/cohabiting/dating, money management, driving, sexual 
relations, daily relations, daily responsibilities, self-care routines, health maintenance, 
and childrearing; Barkley, 2011c). Participants were asked to indicate how much 
difficulty they have functioning effectively in each of the major life activities during the 
past six months, with possible responses ranging from “Not at all” (0) to “Severe” (9). A 
summed total score for the questionnaire was calculated by adding up the individual item 
scores, excluding those items that were answered “Does not apply” (99). The scale is 
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reported to have satisfactory internal consistency, test-retest reliability, and validity 
(Barkley, 2011b).  
The mean impairment score for all participants was 2.071 (SD = 1.583) out of a 
possible maximum mean impairment score of 9. The scores for the scale ranged from 0 to 
7.69. See Table 1 for the mean impairment score, standard deviation and range for each 
pubertal onset group. Cronbach’s alpha for the BFIS is excellent in this sample, with an 
alpha value of 0.96. 
The Risk-Taking Behavior Questionnaire (RTBQ). Participants were asked to 
complete a self-report measure of their engagement in and frequency of specific risky 
behaviours across five domains, including driving, drugs/alcohol/cigarettes, law breaking, 
family, and sexual behaviour.  This is an unpublished measure originally developed to 
survey risk-taking behaviour in a related study of younger adolescents and has been used 
extensively with university students. Preliminary analyses suggest that this measure has 
adequate psychometric properties (Miller, White, Knezevic, Ostojic, & Niemasik, 
manuscript submitted for publication). Participants were asked how frequently they 
engaged in the listed behaviours over the past six months, with possible responses 
ranging from zero (“Never”) to four (“11 or more times in the past six months”). The 
final of the sexual behaviour items, the total lifetime number of sexual partners, was 
scored slightly differently (0 = no sexual partners, 1 = 1-2 sexual partners, 2 = 3-5 sexual 
partners, and 3 = 6 or more sexual partners. Despite the fact that the RTBQ is 
differentiated into five domains, only the summed total score is interpreted. The summed 
total score for the RTBQ was calculated by adding up the individual item scores, with a 
possible maximum score of 99.   
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The mean RTBQ total score for all participants was calculated to be 14.63 (SD = 
9.144), with the scores ranging from 0.00 to 44.0. The RTBQ total score was also 
examined per pubertal onset group, with the early pubertal onset group having a mean 
score of 16.61 (SD = 9.757, range = 1.00 – 42.0), the on-time onset pubertal group having 
a mean score of 13.76 (SD = 8.635, range = 0.00 – 42.0), and the late onset pubertal 
group having a mean score of 14.34 (SD = 9.386, range = 0.00 – 44.0). Internal 
consistency, evaluated by calculating Cronbach’s alpha using all 23 items, was adequate 
with an alpha value of 0.79. 
Data Analyses 
 All analyses were performed using the Statistical Package for Social Science 
(SPSS) for Mac, Version 21.0. Prior to conducting the main analyses the data were 
assessed for patterns of missingness and missing data was subsequently imputed using 
the expectation-maximization procedure. A one-way multivariate analysis of covariance 
(MANCOVA) was initially chosen as the statistical test of choice with puberty onset as 
the independent variable with three factor levels: early, on-time, and late puberty onset. 
MANCOVA was chosen because it was speculated that given the related content of the 
questionnaires the outcome variables would likely be correlated. Further, the number of 
days since the last menstrual period was suspected to be a covariate (K. Milne, personal 
communication, March, 2012). Days since last menstrual period was initially chosen as 
the covariate because fluctuating sex hormone levels during the menstrual cycle have 
been shown to affect performance in a wide range of domains, including fine motor 
performance (Bayer & Hausmann, 2012), prepulse inhibition (Kumari et al., 2010), 
learning and memory (Gasbarri et al., 2008), inhibitory output control (Colzato, Hertsig, 
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van den Wildenberg, & Hommel, 2010), attention (Colzato, Pratt, & Hommel, 2012), and 
female dominance motivation and behaviour (Stanton & Schultheiss, 2007). Moreover, it 
has been argued that ignoring menstrual cycle status of female respondents may bias self-
reporting and clinician’s judgments about numerous syndromes and disorders (Endicott 
& Shea, 1989). This continuous variable was split into two groups: less than or equal to 
14 days or more than 14 days since last menstrual period; with former corresponding to 
the follicular phase of the menstrual cycle and the latter, the luteal phase (Barnett et al., 
2004; Butt, 1979). Notably, however, this variable was found to not be associated with 
the outcome variables, and thus was removed from all further analyses.  
 Relatedly, as described below in greater detail, before proceeding with the 
analysis, verification of the statistical assumptions for MANCOVA was done; revealing 
that the assumptions were not met (described below). All subsequent attempts to remedy 
this problem were unsuccessful. As a result, the decision to proceed with a different 
statistical test (i.e., multinomial logistic regression) was made. Multinomial logistic 
regression was chosen because this statistical procedure is thought to be robust to 
violations of normality and homogeneity of variance-covariance matrices, and makes no 
assumption that the predictors have to be linearly related (Tabachnich & Fidell, 2007, p. 
437). Further advantage of this technique is that it allows for the selection of a reference 
group for all comparisons (Field, 2009, p. 301). In contrast to the MANCOVA, however, 
the outcome variable in the multivariate logistic regression was timing of puberty, with 
three categories: early, on-time, and late puberty onset, whereas the subscale and 
composite totals on the questionnaires served as the predictors.  As was done by Zehr and 
colleagues (2007), quartiles for the summed total score of pubertal development scale 
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were used to categorize early (lowest quartile), on-time (middle-two quartiles), and late 
(highest quartile) pubertal onset.  Next, logistic regression analysis was conducted to 
allow for a direct comparison between the early pubertal onset group and the on-time 
pubertal group. Finally, this was followed up by descriptive analyses.  A p < 0.05 was 
selected as the statistical significance level for all analyses. This is the standard alpha 
value utilized most often by researchers (Field, 2009, p. 281) and was considered 
appropriate given the exploratory nature of the study. Interestingly, Tabachnick & Fidell 
(2007; p. 455) report that Hosmer & Lemeshow (2000) suggest using a less stringent cut-
off, in the range of 0.15 to 0.20, for the inclusion of a variable in order to avoid 
erroneously removing a predictor that may be involved in a suppressor effect. Notably, 
however, as described below the entry method chosen for the step-wise logistic 
regression is designed to minimize Type II error. 
 Missing Data  
Investigation of the absence of data, including the pattern of missingness was 
done in order to address the fact that missing data may bias the analysis and result 
findings (McKnight, McKnight, Sidani, & Figueredo, 2007). Computing the proportion 
of missing data using the sparse matrix method yielded an overall item-non-response rate 
of 0.184%, whereas calculation of the response rate using the complete case method for 
the 253-participant dataset was 18.9%. Correspondingly, the sparse-matrix-to-complete-
case ratio, was calculated to be 0.00976, signifying that the average amount of data 
missing per incomplete case is approximately 0.976%. Further, the messiness index was 
found to be 0.813, indicating a messy missing data pattern in which each participant has 
her own pattern of missing data (McKnight et al., 2007, p. 109). Importantly, a messy 
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missing data pattern suggests that the data is missing completely at random (MCAR). 
Closer inspection of the individual outcome questionnaires (i.e., BAARS-IV, 
BDEFS, DERS, and RTBQ) further supported the conclusion of a scattered pattern of 
missingness, with each questionnaire having an overall item non-response rate less than 
1%. It should be noted that apart from one participant not completing the entire DERS, 
there were no cases in which participants left more than a few items incomplete per 
questionnaire.  With regards to the Puberty Development Scale-Retrospective version 
(PDS-RV), the 6 items used to calculate the total PDS-RV score, and the PDS-RV item 
reflecting age of first menstruation were analyzed for missingness. It should be noted that 
data was considered missing if the individual responded “Don’t Know” or if they left the 
item blank. The overall item non-response rate was calculated to be 3.29% with the 
greatest number of missing items concentrated on items pertaining to growth of body hair 
relative to peers (14.2%) and timing of skin changes relative to peers (7.87%). Pertaining 
to the three demographic variables used to impute PDS-RV missing values, race, weight 
and height, with the latter two used to calculate a Body Mass Index score, only one case 
was missing in the sample for each variable.   
To examine the impact of the missing data and to ensure that the missingness was 
not conditional on the other variables in the data set, Little’s MCAR test was conducted 
(Missing Completely at Random; Little, 1988). Given that the null hypothesis for the test 
is that the data are MCAR, the non-significant result from the Little’s MCAR test (x2 
=7868.937; df = 7830; p = 0.376) suggested that the data are at least Missing at Random 
(MAR), and therefore, the missingness is not dependent on the other values in the data set 
(Little, 1988). In line with the visual inspection of the missing data, and taking into 
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account the existing selection bias in the sample (i.e., sample consisted of those 
participants who voluntarily signed up for the study and completed the questionnaires), 
the conclusion that the data are likely at least missing at random is justified.  
Imputation of Missing Data 
Expectation-Maximization (EM) was used to replace missing values.  As per 
Tabachnick and Fidell (2007, p. 71), EM method provides the “simplest and most 
reasonable approach to imputation of missing data”, when there is evidence that the data 
are at least missing at random. As such, given the minimal amount of missing data, and 
evidence that the values are missing at random, use of EM was deemed appropriate. To 
obtain less biased estimates of the missing data, imputation of missing data was done 
separately for the PDS-RV and the outcome measures. Missing PDS-RV items were 
imputed using the key PDS-RV items (i.e., PDS items: 1, 2, 4, 6, 13, 17, and 21), a 
calculated body mass index (BMI) score and race. The latter two variables were chosen 
because both the BMI score and race have been associated with the timing of pubertal 
onset (Kaplowitz, Slora, Wasserman, Pedlow, & Herman-Giddens, 2001; Lee et al., 
2007).  Inclusion of the other PDS-RV items (i.e., PDS items: 8, 11, 15, 19, 23) led to a 
failure to converge after 100 iterations. Consequently, these items were not included 
because the lack of convergence would lead to unstable estimates. With regards to 
imputing data for the outcome measures using EM, the missing values for the BAARS-IV 
Current scale, BDEFS, BFIS and DERS were done together. The RTBQ items were not 
included because the EM algorithm conducted with these items failed to converge after 
25 iterations, even though Little’s MCAR test was not significant. Again, given that the 
lack of convergence would lead to unstable estimates, missing values for the RTBQ were 
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imputed independently of any other variables in the dataset. The individually imputed 
datasets were combined and all subsequent analyses were conducted using this new 
dataset. Notably, however, although the results presented reflect analysis done using the 
imputed datasets, given the small amount of missing data the original and imputed 
datasets were very similar.  
Analysis of the Assumptions of MANCOVA 
Prior to conducting the main analyses as planned using a MANCOVA, the data 
were first examined to see if the assumption for MANCOVA were met. Although not a 
direct assumption of MANCOVA, examination of univariate normality for the 
independent variable, PDS-RV total score measured as a continuous variable, was done 
to ensure that break-down into groups based on quartiles would be justified and unbiased. 
The assumption of normality for the PDS-RV total score was assessed using tests of 
normality and examination of kurtosis and skewness values. Although, the Kolmogorov-
Smirnov test was significant (p<0.000), the Shapiro-Wilks test was not (p = 0.096), nor 
did kurtosis and skewness values exceed ±2 and ±3, respectively. Further, examination of 
the histogram and Q-Q plots suggested a normal distribution for the PDS total score. 
The assumption of multivariate normality for the outcome variables was assessed 
through examination of the skewness and kurtosis values, the Shapiro-Wilk statistic, and 
bivariate scatterplots.  Given that a necessary, but not sufficient, condition for 
multivariate normality to hold, is to ensure that observations on each dependent variable 
must follow a normal distribution in each group, univariate normality was first examined 
for each variable independently (personal communications, D. Jackson, January 2013; 
Tabachnick & Fidell, 2007, p. 78). This is especially important if inference is an aim 
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(Tabachnick & Fidell, 2007, p. 79). Examination of univariate normality for the BAARS-
IV current scale by visual inspection of Q-Q plots and histogram showed a distribution 
with a positive skew. This conclusion was supported as both tests of normality were 
significant at the p<0.001 level. A positive skew was also observed for all subscale totals. 
Attempts to correct normality by conducting square root and logarithmic transformations 
as recommended by Tabachnick and Fidell (2007; p. 88) were not successful. Similarly, 
examination of univariate normality for the BDEFS and BFIS also revealed non-normal 
distribution of scores; a conclusion supported by significant tests of normality (i.e., 
Kolmogorov-Smirnov (p<0.001) and Shapiro-Wilks tests (p<0.001)) and visual 
inspection of the histograms and Q-Q plots. Further, the assumption of normality was 
also not met for all of the associated subscale totals. In contrast to the BAARS-IV current 
scale, conducting a logarithmic transformation did improve normality for the BDEFS 
total score as indicated by a non-significant Kolmogorov-Smirnov test (p = 0.200) and 
visual inspection of the histogram. It should be noted, however, that the Shapiro-Wilks 
test was still significant for the total score (p = 0.030) after the logarithmic 
transformation, and neither transformation improved normality for the BDEFS subscales. 
Relatedly, performing a square root transformation did improve normality for the BFIS as 
indicated by non-significant Kolmogorov-Smirnov (p = 0.200) and Shapiro-Wilks tests 
(p<0.119), and visual inspection of the histogram and normal Q-Q plots.  Notably, 
logarithmic transformation yielded a negatively skewed distribution. With regards to the 
DERS, examination of normality for the total score revealed a slight positive skew, and 
tests of normality supported conflicting conclusions (Kolmogorov-Smirnov (p = 0.075) 
and Shapiro-Wilks (p = 0.002)). Moreover, evaluation of the kurtosis and skewness 
  34 
 
values showed that they did not exceed their respective cutoffs of ±2 and ±3. Notably, 
visual inspection of the histogram and Q-Q plots did suggest that the distribution was 
positively skewed.  Again, in attempt to fix this slight deviation from normality, square 
root and logarithmic transformations were done (Tabachnick & Fidell, 2007, p. 88) The 
square root transformation made the distribution normal as indicated by non-significant 
tests of normality: Kolmogorov-Smirnov (p=0.200) and Shapiro-Wilks (p = 0.489). 
Further, as depicted on the Q-Q plots and histogram, the data distribution appeared 
normal. No outliers were identified on the box-plot. In line with this finding, the z scores 
for the DERS total score before and after the square root transformation did not exceed 
±3.29. Further, examination of normality for each PDS-RV group showed that the 
assumption of normality was met. In contrast, the subscales on the DERS were not 
normally distributed, and both square root and logarithmic transformations were not 
successful in correcting this deviation from normality. Finally, the assumption of 
univariate normality was also not met for the RTBQ, and conducting square root and 
logarithmic transformations did not help improve normality. Therefore, given that 
univariate normality was violated in nearly all cases, a necessary condition for meeting 
the assumption of multivariate normality, the assumption of a multivariate normal 
distribution was also violated (Stevens, 2009). Fortunately, Stevens (2009) notes that this 
assumption is robust with respect to type I error. 
The assumption of homogeneity of variance-covariance was tested using Box’s M 
test. Box’s M was significant for all predictor variables, indicating that this assumption 
was violated. Box’s M value remained significant after removal of the outliers, further 
supporting the retention of all usable cases. Notably, this test is very sensitive to 
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violations of normality. Further, it is conditionally robust if the group sizes are equal or 
approximately equal (largest/smallest <1.5; Stevens, 2009), which was not the case in the 
present analysis. Therefore, one can be confident in the conclusion that this assumption 
was also violated.  
To ensure that the assumption of independence of observations was met, the data 
collection process was designed to minimize any chance that the responses for one person 
would affect the ratings on the measures for another. For instance, participants were 
always spaced far enough apart while completing the questionnaires to not allow for 
copying of responses, and they were not given the opportunity to communicate or share 
their responses with one another. That said, the shared school environment participants 
have may limit complete independence of observations. Further, each case reflects the 
responses of a unique participant. In the one case that a participant completed the study 
twice, the responses from their second time was removed from all analyses. Therefore, it 
can be argued that the assumption of independence of observation was met. This is 
especially important given that the assumptions of multivariate normality and 
homogeneity of variance-covariance matrices were not met. 
Finally, the assumption of adequate sample size was assessed. Including all 
identified outliers, and after removing the repeated case and the two individuals who 
reported a history of head injury, a final sample of 251 was used for subsequent analyses. 
Using quartiles to create pubertal timing categories led to unequal group sizes, with the 
early pubertal onset group having 64 participants, the on-time pubertal onset group had 
127 participants, and the late pubertal onset group had 60 participants. The total sample 
size/number of variables ratio was calculated to be 41.8:1, which met the criteria that the 
  36 
 
ratio should be at least 20:1 (Stevens, 2009). Thus, the assumption of adequate sample 
size holds, and one can be more confident in the interpretation of the results. It should be 
noted that the late pubertal onset group was removed for the logistic regression analysis 
described below, bringing the final sample size for this analysis to 191 participants. 
Attempting to improve normality, identification and removal of outliers and 
influential observations was done by entering all variables of interest in a linear 
regression model (personal communication, D. Jackson, May 2013). In order to detect 
univariate outliers, standardized residuals were examined. Using z = ± 3.29 standard 
deviations from the mean as the cut-off, no outliers were detected. Mahalanobis distance 
(D2) was calculated in order to detect multivariate outliers. Using the D2 cut-off value of 
49.728 (df = 23, k = 23, α = 0.001), 11 cases were detected. These 11 outliers were 
removed and the assumption of multivariate normality and homogeneity of variances was 
reassessed. The assumption of multivariate normality was still violated, and no 
significant improvements in skewness and kurtosis values were observed following the 
removal of the cases. Similarly, bivariate scatterplots revealed no change in normality, 
and thus the outliers on y were retained. Finally, no influential observations were found in 
the data, as no Cook’s distance value came close to 1. Further justifying keeping these 
cases, when data is not normally distributed it is difficult to identify if those cases are not 
from the population of interest.   
Justification for Conducting Multinomial Logistic Regression and Logistic 
Regression 
As a result of violating both the assumption of normality and homogeneity of 
variance, and given that the only assumptions met were adequate sample size and 
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independence of observations, conducting a parametric test, such as a MANCOVA, is not 
justifiable. Consequently, the analysis needed to be conducted using either a non-
parametric test, or a test not requiring the strict adherence to these assumptions. Thus, 
multinomial logistic regression, given that it is robust to violations of normality and 
homogeneity of variance-covariance matrices, was chosen (Tabachnick & Fidell, 2007, p. 
437).  Notably, logistic regression does assume independence of observations, linearity, 
and absence of multicollinearity (Tabachnich & Fidell, 2007, p. 443; Field, 2009, p. 273). 
As described above, the assumption of independence of errors/observations was met. 
Similarly, for all but two predictors (i.e., BDEFS Self Management of Time Score and 
BDEFS Self-Regulation of Emotion Score) the assumption of linearity of the logit was 
met. This assumption was evaluated by examining “if the interaction term between the 
predictor and its log transformation was significant” when entered in the logistic 
regression model (BDEFS Self Management of Time Score: p = 0.036 and BDEFS Self-
Regulation of Emotion Score: p = 0.035; Field, 2009, p. 273). Finally, testing for 
multicollinearity revealed no violation of this assumption as the tolerance values for all of 
the predictors were not less than 0.1, nor were VIF values greater than 10 (Field, 2009, p. 
297).  
In addition to being more flexible than other techniques, multinomial logistic 
regression allows for the selection of a reference group for all comparisons (i.e., on-time 
pubertal onset; Field, 2009, p. 302), as does logistic regression. Stepwise multinomial 
logistic regression utilizes statistical criteria to include and remove predictors from the 
equation (Tabachnick & Fidell, 2007, pp. 454). Although criticized for this, this 
methodology serves a good purpose in screening or hypothesis generating (Tabachnick & 
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Fidell, 2007, p. 454), which is appropriate given the exploratory nature of this study. 
Although underutilized in social science research, both multinomial and binary logistic 
regression is a very useful method when the outcome variable is categorical and the 
predictors are continuous and/or categorical (Davis & Offord, 1997). Stepwise is 
defensible when conducting analyses in an area where there is limited or no existing 
research (Field, 2009, p. 272). Moreover, it allows for the selection of those variables that 
are significantly associated with pubertal onset, while concurrently removing predictors 
that have less of an impact. When using a stepwise method, the backward method is 
preferred over the forward method because it allows for the detection of suppressor 
effects, and thus is less likely to cause a Type II error (Field, 2009, p. 272). Finally, with 
regards to the test statistic to be used in the stepwise method, the likelihood ratio method 
is preferred, given that the Wald statistic may produce inaccurate results under certain 
conditions (Field, 2009, p. 272).  For these reasons, multinomial logistic regression and 
logistic regression were both done using the step-wise backward entry method, with the 
likelihood ratio statistic used as the criterion for comparing the models with and without 
the predictor.  This procedure was later followed-up with step-wise forward entry 
method, to see if the same set of predictors have significant score statistics. 
Multinomial logistic regression was done first because it allowed for the 
comparison of both the early and late pubertal onset groups to the on-time pubertal onset 
group. This analysis revealed that any significant differences on the administered 
questionnaires only existed between the early and on-time pubertal onset groups. 
Consequently, and in concordance with the hypothesis predicting the negative 
consequences of early pubertal onset, this analysis was followed up with logistic 
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regression, comparing these two groups. This analysis paralleled the findings from the 
multinomial logistic regression and were the findings that were interpreted.  
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CHAPTER IV 
Results 
Logistic Regression Model 
 For each logistic regression analysis, interpretation of the goodness-of-fit test 
using the “-2 Log-Likelihood Statistic” was performed in order to assess how well the 
logistic regression model fit the data. Further, examination of the B-value 
(unstandardized regression coefficient), odds ratio, and significance of the Wald statistic 
(measure of the unique contribution of each predictor) was done to determine how well 
each predictor in the model fit the data (Field, 2009, p. 284-89). In this study, the 
potential explanatory variables were entered in groups based on their corresponding 
questionnaires. That is, all subscales of one questionnaire were entered independently of 
the subscale totals corresponding to the other questionnaires. Relatedly, in order to avoid 
issues of multicollinearity, symptom count totals and total scores were not entered along 
with the matching subscale totals in the same logistic regression analysis. Instead, 
symptom counts corresponding to the same questionnaire were entered together, whereas 
all questionnaire total scores were entered and analyzed together to determine whether or 
not they are significant predictors in the model.  Finally, all variables that were identified 
as significant in the previous analyses were entered in the same logistic regression 
analysis. 
Outcome Variable in the Logistic Regression Analysis 
 The outcome variable for all of the logistic regression analyses was pubertal 
timing, determined by the participant’s score on the PDS-RV questionnaire.  As 
described above, pubertal onset had three factor levels: early, on-time and late pubertal 
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onset, and quartiles for the summed total score of pubertal development were used to 
categorize early (lowest quartile), on-time (middle-two quartiles), and late (highest 
quartile) pubertal timing. For the purposes of comparing early to on-time pubertal onset 
using logistic regression, pubertal onset was operationalized as a dichotomous variable, 
with those characterized as having on-time pubertal onset given a value of 0 and those 
identified as having early pubertal onset given a value of 1. This coding was chosen in 
order to aid in interpretation by labeling the on-time pubertal onset category as the 
reference group. As such, the odds ratio was interpreted at the ratio of the probability of 
membership in the early pubertal onset group occurring and the probability of this not to 
occur when the predictor variable increases by one. After removing two participants from 
the analysis because they disclosed having a head injury resulting in a loss of 
consciousness, the number of participants categorized in the on-time and early pubertal 
onset groups was 127 and 64, respectively. 
Independent Variables in the Logistic Regression Analysis 
 Barkley Adult ADHD Rating Scale – IV: Self-report – Current Symptoms. 
The four subscale totals of the BAARS-IV self-report of current symptoms questionnaire 
(i.e., Inattention, Hyperactivity, Impulsivity and Sluggish Cognitive Tempo) were entered 
in step-wise backward entry logistic regression model. Assessment of model fit was done 
by examining the change in the maximum likelihood statistic when the predictors were 
added to the model (i.e., examination of the model chi-square statistic). This showed that 
the addition of the four subscales did not significantly improve model fit over the model 
when only the constant was included, although the chi-square value did approach 
significance (initial -2 log likelihood = 243.608; Goodness of fit = 240.037; χ2 (1) = 
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3.571, p = 0.059). Interestingly, the Hosmer-Lemeshow test produced a non-significant 
chi-square value (χ2 (8) = 2.913, p = 0.940), indicating an improvement in the model, as 
a good model produces a non-significant chi-square value (Tabachnick & Fidell, 2007, p. 
459). With regards to the unique contribution of each predictor, none of the variables 
were identified as making a significant contribution to the prediction of pubertal timing 
membership, although as depicted in Table 2, the Wald statistic for the Inattention 
subscale total approached significance.  Notably, the odds ratio is similar to those 
predictors that were significant. Thus, the effect size is comparable despite the non-
significance.  Additional measures of effect were provided with the Cox and Snell’s 
measure (R2 = 0.019) and Nagelkerke’s adjusted value (R2 = 0.026). It is important to 
note that the Cox and Snell value takes into account sample size and underestimates 
effect size as it cannot achieve a maximum value of one (Tabachnick & Fidell, 2007, p. 
460).   Finally, follow-up analysis using a step-wise forward entry logistic regression 
method did not produce a model. 
In contrast to the non-significant finding noted above, when symptom counts for 
the four subscales were entered in a logistic regression analysis (stepwise backward 
entry), the current Inattention Symptom count score was identified as a significant 
predictor. Examination of the model chi-square statistic revealed an improvement in 
model fit with the addition of this variable (initial -2 log likelihood=243.608; Goodness 
of fit=237.989; χ2 (1) = 5.619, p = 0.018), and the Hosmer-Lemeshow test produced a 
non-significant chi-square value (χ2 (2) = 1.403, p = 0.496). Inspection of the measures 
of effect sizes, Cox and Snell (R2 = 0.029) and Nagelkerke’s (R2 = 0.040) values 
suggested stronger effects. Further, entering the variables as symptom counts instead of 
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totals improved classification accuracy to 68.1%. Table 3 includes regression coefficients 
in the final model. 
As depicted in Table 3, the odds of correctly predicting group membership are 
increased by 27.0% with the addition of the Inattention Symptom count to the model. In 
short, as the inattentive symptom count increases, the more likely one will have had an 
earlier pubertal onset.  
Barkley Deficits in Executive Functioning Scale. As was done for BAARS-IV 
scales, the five BDEFS subscale totals (i.e., Self-Management to Time, Self-
Organization/Problem Solving, Self-Restraint, Self-Motivation, and Self-Regulation of 
Emotion) were simultaneously entered in the logistic regression analysis, using the 
backward step-wise method. A significant model chi-square statistic (initial -2 log 
likelihood = 243.608; Goodness of fit = 237.928; χ2 (1) = 5.680, p = 0.017) revealed an 
improvement in model fit with the addition of the Self-Regulation of Emotion subscale 
total to the model. Further, the Hosmer-Lemeshow test produced a non-significant 
finding (χ2 (8) = 6.581, p = 0.582) indicating an improvement in the model (Tabachnick 
& Fidell, 2007, p. 459). With the inclusion of the Self-Regulation of Emotion subscale 
total the model classified 66.5% of participants correctly. Table 4 includes regression 
coefficients in the final model. 
As illustrated in Table 4, as the variable Self-Regulation of Emotion score 
increases by one, participants are 1.053 times more likely to be classified in the early 
pubertal onset group. That is, the odds of correctly predicting classification increased by 
5.3%. Cox and Snell’s measure (R2=0.029) and Nagelkerke’s adjusted value (R2=0.041) 
provide measures of effect size. Follow-up analysis using step-wise forward entry method 
  44 
 
confirmed that Self-Regulation of Emotion subscale score is making a significant 
contribution to the prediction of the timing of pubertal onset.  
 The BDEFS form also allows for the calculation of an executive-function (EF) 
symptom count that is a measure of the number of items that were answered with a 
sufficiently rare response suggesting the presence of clinical symptoms of an executive 
functioning deficit. Unlike the BAARS-IV scales, the BDEFS does not have symptom 
counts for the individual subscales. As such, only the EF symptom count was entered as a 
continuous variable in the logistic regression analysis (step-wise: backward entry). 
Assessment of model fit after the addition of this variable suggested an improvement in 
model fit (initial -2 log likelihood=243.608; Goodness of fit=238.941; χ2 (1) = 4.667, p = 
0.031). Further, as shown in Table 5, the variable was identified as a significant predictor, 
although its odds ratio was relatively small. With the addition of this variable the 
accuracy of the classification improved to 67%, with the odds of correctly predicting a 
participant’s timing of pubertal onset increased by 2.6%. This suggests that a participant 
is more likely to have had an early pubertal onset if they reported having a higher EF 
symptom count.  
Difficulties in Emotion Regulation Scale. The DERS yields a total score and six 
subscale scores: (1) Nonacceptance of emotional responses (Nonacceptance), (2) 
Difficulties engaging in goal directed behaviour (Goals), (3) Impulse control difficulties 
(Impulse), (4) Lack of emotional awareness (Awareness), (5) Limited access to emotion 
regulation strategies (Strategies), (6) Lack of emotional clarity (Clarity). The six subscale 
totals were entered in the step-wise logistic regression analysis using the backward entry 
method. Examination of model fit revealed a significant model chi-square statistic (initial 
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-2 log likelihood = 243.608; Goodness of fit = 239.251; χ2 (1) = 4.357, p = 0.037) 
indicating an improvement in model fit with the addition of the Impulse subscale total to 
the model. Relatedly, the non-significant Hosmer-Lemeshow test (χ2 (7) = 7.867, p = 
0.344) also suggested an improvement in the model (Tabachnick & Fidell, 2007, pp. 
459). With the inclusion of the Impulse subscale total the model classified 66.5% of 
participants correctly. As depicted in Table 6, the odds ratio for the Impulse subscale is 
1.070, indicated that the odds of correctly predicting classification increases by 7.0% 
with the addition of this variable. In other words, as the Impulse subscale score increases 
by one, participants are 1.070 times more likely to be classified in the early pubertal onset 
group. Cox and Snell’s measure (R2=0.023) and Nagelkerke’s adjusted value (R2=0.031) 
provide measures of effect size. Again, follow-up analysis using a step-wise forward 
entry method also identified the Impulse subscale as making a significant contribution to 
improving model fit of the data.  Table 6 includes regression coefficients in the final 
model. 
All Total Scores. The total scores from all six questionnaires were entered in the 
step-wise logistic regression analysis using the backward entry method. Examination of 
model fit revealed a significant model chi-square statistic (initial -2 log likelihood = 
239.192; Goodness of fit = 231.491; χ2 (2) = 7.701, p = 0.021) indicating an 
improvement in model fit. Further suggesting an improvement in the model with the 
addition of the predictors is the non-significant Hosmer-Lemeshow test finding (χ2 (8) = 
12.305, p = 0.138; Tabachnick & Fidell, 2007, p. 459). In fact, with the inclusion of the 
Barkley’s Functional Impairment Scale total and the Risk Taking Behaviour 
Questionnaire total scores the overall accuracy of the classification improved to 67.7%. 
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Table 7 includes regression coefficients in the final model. 
As displayed in Table 7, using the backward-entry method neither predictor left in 
the final model had a significant Wald statistic, although both approached significance. 
This is especially the case for the BFIS Total score as it had an odds ratio of 1.210, 
indicating that the odds of correctly predicting classification increases by 21% with the 
addition of this variable. Notably, when the same set of predictors were entered in a 
forward step-wise entry method, the BFIS total score was identified as making a 
significant contribution to the prediction of group membership. That is, an individual’s 
score on the BFIS significantly predicted whether they were classified in the early or on-
time pubertal onset group (see Table 8).  
As indicated by the odds ratio displayed in Table 8, as the BFIS increases by one 
unit, participants are 1.239 times more likely to be classified in the early pubertal onset 
group. Thus, the odds of correctly predicting classification increased by 23.9%. 
 For three of the six questionnaires used in the study it was possible calculate 
symptom counts: BAARS-IV Childhood symptom count, BAARS-IV Current symptom 
count and BDEFS-EF symptom count. These were entered in the step-wise logistic 
regression analysis using the backward entry method. Examination of model fit following 
the addition of these variables revealed an improvement in model fit as illustrated by a 
significant model chi-square statistic (initial -2 log likelihood = 243.608; Goodness of fit 
= 237.223, χ2 (1) = 6.385, p = 0.012). Estimates of effect size were provided with the 
Cox and Snell’s measure (R2 = 0.033) and Nagelkerke’s adjusted value (R2 = 0.046). 
Further, inspection of the classification table revealed that the adjusted model was able to 
correctly classify 67.5% of participants. Table 9 includes regression coefficients in the 
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final model. 
As shown in Table 9, the odds ratio for the BAARS-IV current total symptom 
count is 1.182, indicated that the odds of correctly predicting classification increases by 
18.2% with the addition of this variable. That is, as the number of BAARS-IV current 
symptoms increases by one, participants are 1.182 times more likely to be classified in 
the early pubertal onset group than the on-time pubertal onset group. Follow-up analysis 
using a step-wise forward entry method confirmed this finding. 
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CHAPTER V 
Discussion 
Review of Research Question 
 The aim of the current study was to investigate how the timing of female pubertal 
maturation is associated with the extent of ADHD symptoms and related impairments in 
a non-clinical female emerging adult sample. Despite the growing evidence that 
circulating sex hormones during puberty may help explain the subtle sex differences that 
exist in the symptom profile, neuropathology and clinical sequelae of ADHD, there is 
limited research in this area. Consequently, this work was primarily an exploratory study, 
with minimal past research to guide hypothesis generation. That said, it was predicted 
that early pubertal onset would be associated with higher levels of ADHD symptoms, 
difficulties in emotion regulation, impairments in daily functioning, and risk-taking 
behaviour. 
Overview of Research Findings 
Using logistic regression models, significant contributory factors were identified 
to classify those who reported having an earlier pubertal onset relative to their peers. 
Overall, the present findings suggest that early puberty is associated with more current 
symptoms of ADHD and greater impairment on a variety of ADHD-related factors. 
These factors may be categorized in four domains: (1) deficits in attention, (2) difficulties 
in emotion regulation, (3) psychosocial impairment, and (4) risky behaviour. As may be 
predicted from existing literature suggesting that ADHD females present with more 
inattentive rather than hyperactive/impulsive symptoms (Gaube & Carlson, 1997; 
Nussbaum, 2011), early pubertal timing in this non-clinical female sample was not 
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associated with current levels of hyperactivity and impulsivity, nor with self-regulation 
difficulties within domains such as self-restraint and self-motivation.  
General Discussion 
Deficits in attention. The present findings suggest that pubertal onset is 
associated with current level of inattentive symptoms, such as having difficulties in 
sustaining attention, difficulty following instructions, experiencing frequent forgetfulness 
in daily activities, and losing things. Specifically, as the count of current inattentive 
symptoms increases, the odds of an individual reporting they matured earlier than their 
peers increase.  This finding provides empirical support for the influence of pubertal 
timing on deficits in inattention, and is consistent with the hypothesis that the rise in 
inattention symptoms may be the consequence of the changes in the hormonal milieu 
during puberty; a developmental trajectory that may be unique to females (Nussbaum, 
2012). This may be especially important if considered in light of the fact that many adult 
females who exhibit impairments in attention are often misdiagnosed as having other 
psychopathology (e.g., dysthymia when inattentive symptoms are present alongside low 
levels of arousal; Nadeau & Quinn, 2002a, 2002b as cited in Nussbaum, 2012; Wender, 
Wolf & Wasserstein, 2001), and comorbidities for which a role of puberty onset has been 
suggested, such as Major Depressive Disorder (Martel et al., 2009). 
Difficulties in emotion regulation. Exploration of the association between the 
timing of pubertal onset and deficits in emotion regulation revealed a significant 
contribution of emotion regulation factors in predicting pubertal onset group 
membership. Specifically, as individuals reported greater deficits in self-regulation of 
emotion, by endorsing items such as “Overreact emotionally”, “Having trouble calming 
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myself down once I am emotionally upset”, and “Unable to manage my emotions in order 
to accomplish my goals successfully or get along well with others”, the more likely they 
would be to be classified in the early pubertal onset group. Similarly, reporting more 
impulse control difficulties (e.g., disclosing having difficulty controlling behaviours and 
emotions when upset) was associated with higher odds of having matured earlier relative 
to other females. Again, in line with these findings, affect lability and emotional 
impulsivity have been implicated in ADHD (Barkley, 2009; Barkley & Murphy, 2010; 
Sobanski et al., 2010), and emotional regulation difficulties have been linked to the rise 
in internalizing symptoms in girls with ADHD post-puberty (Lee & Hinshaw, 2006). 
These findings help highlight the importance of considering  emotional impulsivity and 
poor emotional self-regulation as central features of ADHD in females. There continues 
to be a need for further studies examining deficits in emotional regulation in an ADHD 
sample (Surman et al., 2013).  
Psychosocial impairment. Deficits in psychosocial functioning are a hallmark of 
many mental disorders, including ADHD (Biederman et al., 1993). Correspondingly, 
those who reported higher levels of psychosocial impairment across several domains 
were more likely to experience puberty earlier than their age-mates. Graber and 
colleagues (2004) demonstrate a similar finding, showing that girls with earlier pubertal 
onset report having poorer adjustment than girls who met pubertal milestones ‘on-time’.  
Specifically, they reported difficulties with the quality of their interpersonal relationships, 
having smaller social support networks and lower life satisfaction. This is interesting 
given that there is overwhelming evidence that both children and adults with ADHD 
show impairments in numerous areas, such as school/work and in interpersonal 
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relationships (Barkley et al., 2002); a finding also noted for females with ADHD 
(Biederman et al., 1999). Specifically, Biederman and colleagues (1999) report impaired 
scores in global, academic and family functioning for girls with ADHD. Further, this is in 
line with the finding from the present study, showing a significant positive correlation 
between the total current number of ADHD symptoms (r = 0.452, p< 0.001) and mean 
functional impairment. The under-identification of females with ADHD means that many 
girls with considerable functional difficulties will continue to have their difficulties 
unacknowledged and untreated.  This finding supports the need for clinicians to pay close 
attention to impairments in several domains of psychosocial functioning, especially in 
girls who begin to mature earlier than others.  
Risky behaviour. In line with previous reports noting the negative consequences 
of early puberty onset on adolescent risk-taking behaviour (Downing & Bellis, 2009), 
early pubertal onset were associated with greater report of risk-taking behaviour in this 
sample of young adults. This finding corroborates previous cross-sectional and 
longitudinal studies that have linked early maturation with higher prevalence of risky 
behaviour, including unhealthy substance use and risky sexual behaviour (Downing & 
Bellis, 2009; Witt, 2007). For instance, Biehl and colleagues (2006) report an association 
between early pubertal maturation and higher alcohol use and heavy drinking in late 
adolescence and young adulthood. In contrast, a study exploring the relationship between 
the age at menarche with current smoking, and heavy use of alcohol and other drugs in 
the past year among 14-15 year-old Canadian girls sampled from the National 
Longitudinal Survey of Children and Youth, revealed no association (Al-Sahab, Ardern, 
Hamadeh, & Tamim, 2012). Interestingly, Wichstrom (2001) reports the use of the PDS 
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over other measures of pubertal timing reveals higher correlations between pubertal 
timing and adolescent substance use. The present study adds to the current literature by 
providing evidence to suggest that early pubertal timing is also associated with risky 
behaviour in domains that have been explored to a lesser extent, such as risky driving 
behaviour or rule breaking. It has been argued that elevations in hormone secretion at 
puberty alter reward circuits during adolescence, influencing reward seeking behaviour, 
such as alcohol consumption (Witt, 2007). Reciprocally, drinking behaviour during post-
pubertal development in turn influences brain development, including the effects of sex 
hormones, via mechanisms not yet understood (Witt, 2007). It is important to note, 
however, that the relationship between pubertal timing and subsequent substance use has 
been explained with reference to other hypotheses, such as the Deviance Hypothesis 
(Petersen & Taylor, 1980, as cited in Wichstrom, 2001). 
Interpreting Current Findings Within a Neurobiological Conceptual Framework. 
 It has been argued that, in contrast to reports that ADHD is more common in 
males than in females during childhood, there is less of a discrepancy in adult ADHD 
prevalence rates between males and females (Nussbaum, 2012). This increase in 
representation of females with ADHD in adolescence and adulthood suggests a potential 
organizational influence of sex hormone exposure during puberty (Nussbaum, 2012). In 
turn, these organizational effects of sex hormones on psychological symptoms and 
behaviour, which are dependent on the timing of puberty onset, should be observable 
post-puberty (Sisk & Zehr, 2005; Zehr et al., 2007). This assertion is supported by the 
current findings suggesting that alterations in brain development as a consequence of 
earlier hormonal exposure during adolescence are associated with ADHD related 
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symptomology and psychosocial functioning in emerging adulthood. Relatedly, as an 
individual reports an increasing number of clinical symptoms of an executive functioning 
(EF) deficit, the odds of them having an earlier pubertal onset increase. “Hormone-
dependent remodeling” of neural circuitry during puberty has been suggested as the 
potential explanatory mechanism (Sisk & Zehr, 2005; Zehr et al., 2007).  
As described above, deficits in the prefrontal cortex and/or neural circuits linking 
the prefrontal cortex to subcortical regions have been implicated in ADHD (Biederman, 
2005; Nigg & Casey, 2005).  Notably, these brain regions are associated with 
catecholamine neurotransmitter systems (e.g., dopamine) that have also been linked to 
ADHD and have been the target of stimulant medication (Biederman, 2005; Halperin & 
Shulz, 2006). Increase in circulating sex hormones, specifically estrogen, is thought to 
induce an increase in the number of dopamine receptors (Fink, Rosie, Grace, & Quinn, 
1996 as cited in Nussbaum, 2012). This increase in dopamine receptors with puberty is 
hypothesized to at least partly explain the increase in symptoms post-pubertal adolescents 
and young adults (Nussbaum, 2012). In animal models, male rats show an increase in 
dopamine receptors pre- and post-puberty, and approximately half-fold decrease by 
adulthood, whereas females rats do not display this pattern of over-production and 
elimination of dopamine receptors (Andersen & Teicher, 2000). Andersen & Teicher 
(2000) suggest that the lack of pre-programed elimination of dopamine receptors in the 
striatum in ADHD females may explain why there is persistence of problems into 
adulthood. Further, they hypothesize that delayed pruning of dopamine receptors in the 
pre-frontal cortex, may explain why motoric symptoms of ADHD tend to diminish post-
puberty, whereas attentional difficulties persist (Andersen & Teicher, 2000). This has 
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been suggested as an explanation for the gender differences in the timing of symptom 
presentation and clinical sequelae. Importantly, these neural circuits develop into early 
adulthood, and it is likely that sex hormones influence the structural and neurochemical 
development in many other complementary ways (i.e., influencing synaptogenesis, 
dendritic elaboration, and myelination), via mechanisms not yet completely understood 
(Sisk & Zehr, 2005).  
In applying this explanation for the present findings, it is important to remember 
that early puberty onset needs to be considered within the context of family history, racial 
and/or ethnic differences, pre-pubertal body mass index (BMI), geographic and 
meteorological context, social environment, and medical history (Posner, 2006; Wales, 
2011). That is, other factors may mediate or moderate the observed relationship between 
the timing of puberty and ADHD-related symptoms and behavioural impairments in 
adulthood. In fact, when current BMI, which is usually associated with pre-pubertal BMI 
(Must et al., 2005), was entered into each logistic regression model, the effect size for 
each model increased while the individual predictors listed above remained significant.  
Although a hormonal mechanism may play a part in explaining both the current 
findings and gender differences in ADHD symptom onset and presentation, alternative 
explanations are also worth noting. For instance, reports of higher adult ADHD 
prevalence rates among females may be a reflection of poor symptom recognition among 
girls by parents and teachers and the inadequacy of current diagnostic criteria in 
identifying females with ADHD (Nussbaum, 2012). Other neurobiological mechanisms, 
independent of hormonal influences, may also be responsible, such as neurogenesis and 
synaptogenesis. Goldstein and Gordon (2003; as cited in Nussbaum, 2012) write that this 
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increase in prevalence post-puberty may be suggestive of a “less severe form of the 
disorder in younger females”. Further, it is important to remember that the changing 
social norms and expectations accompanying pubertal onset may also play a role in the 
current presentation of ADHD symptoms and related impairments. It has been argued 
that early maturing girls have fewer resources to successfully adjust to the changes 
accompanying puberty than later maturing girls, and as a consequence are more likely to 
experience emotional and behavioural problems (Mendle, Turkheimer, & Emery, 2007). 
For instance, early maturing girls are more susceptible to early substance use (Bratberg, 
Nilsen, Holmen, & Vatten, 2005; Wiesner & Ittel, 2002), sexual behaviour (Flannery, 
Rowe, & Gulley, 1993), delinquency (Mendle et al., 2007), In turn, these experiences 
may affect current symptom presentation via their direct or indirect impact on the 
development of the nervous system post-puberty.  
Limitations of the Present Study 
The findings from the present study are limited by several factors. First, by using 
a non-clinical university sample, one is limited in the conclusions that are warranted with 
regards to the nature of ADHD in females and in the generalizability of the findings.  
Notably, however, use of only clinic-referred ADHD females may also not be justified 
given that it has been argued that clinic-referred female ADHD samples may not be 
representative of the typical manifestation of ADHD in females (Gaub & Carlson, 1997). 
Thus, future studies should aim to capture as large of a community sample of females 
with ADHD as possible. Further limiting generalizability, the sample in the current study 
did not have an equal representation of all race/ethnic groups to allow for an accurate 
evaluation of any racial/ethnic differences that have been associated with pubertal timing, 
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but the breakdown accurately represented the local population. Second, it may be argued 
that the use of a retrospective, self-report measure does limit the accuracy of the 
conclusions that can be made. Yet, there is evidence to suggest that retrospective 
estimates of pubertal timing are relatively accurate (Dubas, Graber, & Petersen, 1991).  
Relatedly, while collateral information was not collected to corroborate self-report of 
symptoms, Barkley, Knouse and Murphy (2011) report moderate to high agreement 
between adult self-report and others-report with regards to current symptoms and 
impairment. Third, the use of a cross-sectional design does not warrant causational 
conclusions regarding the effect of pubertal timing on ADHD symptoms in emerging 
adulthood. Finally, the choice of using logistic regression analysis in this study may be 
methodologically confusing given that one is retrospectively predicting from current 
symptoms. It is worth noting, however, that other studies examining factors predictive of 
early puberty have utilized this technique (Downing & Bellis, 2009).  
Unique Contributions of the Present Study 
 There are several strengths of the present research worth noting. First, the 
literature is limited with studies exploring the relationship between pubertal timing and 
ADHD related symptoms and impairments later in life. In fact, the author is unaware of 
any similar studies that have been conducted within the Canadian context. Curbing this 
gap is important in addressing an overlooked public health concern (i.e., the lack of 
clinical and research attention paid to symptom presentation and functional difficulties of 
females with ADHD). Second, as per the expert recommendations (personal 
communication with Russell Barkley, October 2011), the study takes advantage of self-
report behaviour rating scales that have been suggested to be more sensitive in capturing 
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female-specific difficulties (Mahone, 2010). Similarly, the measure of pubertal timing 
used in the study incorporates multiple developmental aspects of pubertal status, and not 
just age at first menarche, providing a more comprehensive estimation of pubertal onset. 
Third, although logistic regression analysis is commonly used in cross-sectional 
epidemiological studies, many fewer studies in the social sciences take advantage of this 
technique. This statistical method proved to be an appropriate technique in this 
circumstance when the violation of several statistical assumptions made the use of other 
techniques unjustified.  
Clinical Implications 
The findings from the current study lend support for the argument that there is a 
need for further research examining gender differences in ADHD across the lifespan.  
Notably, although it does not speak directly to the need for modifying diagnostic 
thresholds, or using gender-specific diagnostic criteria to address potential gender 
differences, it does highlight the potential influence of sex hormones in symptom 
presentation and clinical sequalae of ADHD. This research is especially warranted when 
considered in light of the fact that relative to males with ADHD, adult females with 
ADHD report having a greater number of problems, yet fewer assets (Arcia & Conners, 
1998, as cited in Rasmussen & Levander, 2009). Further, exploration of the impact of 
early pubertal onset on cognitive and psychosocial function is justified given that there is 
a trend toward girls beginning puberty at earlier ages (Al-Sahab, Ardern, Hamadeh, & 
Tamim, 2010; Gluckman & Hanson, 2006; Tanner, 1991, as cited in Posner, 2006). By 
improving our current understanding of the presentation of ADHD in females, we might 
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be better able to identify and improve quality of care given to females with ADHD, and 
thus potentially aiding in the establishment of sex specific interventions.  
Conclusion and Future Directions 
The present findings do not provide evidence for a causational relationship 
between pubertal timing and ADHD symptoms in emerging adulthood. They do, 
however, provide preliminary evidence for a relationship between these two variables. 
That is, hormonal-dependent organizational influences during puberty seem to be 
associated with ADHD symptoms and behaviours later in life, with earlier pubertal onset 
linked to more deficits in attention, emotion regulation, and psychosocial functioning, 
and greater reports of risky behaviour. It should be noted, however, that none of these 
symptoms are specific to ADHD, and many individuals with other psychopathology will 
present with some subset of these symptoms and impairment. Nevertheless, these 
findings provide support for a potential organizational effect of sex hormones during 
pubertal development.  
The study sheds light on the impact of early puberty and its findings help pave the  
way for future research. Given that this is an unexplored research area, the possibilities 
for future studies are numerous. This includes conducting a longitudinal study examining 
symptom presentation across development, with special attention given to girls who 
experience precocious puberty. This would not only overcome the limitations of a cross-
sectional design, but would also alleviate any limitations that may be due to the use of 
retrospective measures of pubertal onset.  Relatedly, it is important to remember that 
organizational effects of sex hormones are not necessarily exclusive or independent of the 
potential transient activational effects of sex steroids. As such, future work should 
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examine symptom presentation during pubertal development, allowing for a better 
understanding of both short-term and long-term effects of pubertal timing. 
 Despite the fact that ADHD symptoms reflect extremes on the developmental 
continuum allowing for the investigation of ADHD symptoms in a nonclinical sample, 
use of a clinical sample would more directly address the research question. This would 
require access to a community sample of females with ADHD, which has been noted to 
be a difficult population to recruit. Relatedly, it would be interesting to examine if there 
are any subtype differences with regards to the influence of sex hormones during puberty. 
 Future studies could also add to the growing literature by examining or 
controlling for the influence of factors known to impact pubertal timing, such pre-
pubertal BMI, socioeconomic status, and number of childhood illnesses (Downing & 
Bellis, 2009). These factors may mediate or moderate the identified relationship. Further, 
future studies should examine the interplay between hormonal influence and growing 
social demands on symptom presentation in emerging adulthood. It would also be 
interesting to further explore how the identified deficits in attention and emotion 
regulation in emerging adulthood contribute to the reported psychosocial functional 
impairments and higher risk taking behaviour in females with ADHD.  
Overall, the present research aids in the understanding of the impact of 
differential pubertal timing and the role hormonal exposure during puberty may play in 
explaining the differences in gender prevalence rates of ADHD and symptom profiles. 
Future studies are needed to further examine the influence that elevations in sex 
hormones during puberty may have in increasing ADHD symptom presentation, and how 
and to what extent these effects are permanent and observable in adulthood.  
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Table 1 
Mean, Standard Deviation and Range for Each Questionnaire by Pubertal Onset Group 
Questionnaire Pubertal Onset Group Mean 
Standard 
Deviation Range 
PDS-RV 
(maximum score = 30) 
Early 12.21 1.966 6.00 – 14.8 
On-time 17.22 1.314 15.0 – 19.2 
Late 22.74 2.156 19.9 – 29.0 
All Participants 17.26 4.084 6.00 – 29.0 
BAARS-IV Current 
Symptoms Total Score 
(maximum score = 108) 
Early 28.28 6.846 19.0 – 50.0 
On-time 26.37 5.860 18.0 – 51.0 
Late 27.95 7.229 18.0 – 49.0 
All Participants 27.24 6.498 9.00 – 31.0 
BAARS-IV Current 
Inattention Subscale Score 
(maximum score = 36) 
Early 14.83 4.410 9.00 – 31.0 
On-time 13.69 3.574 9.00 – 26.0 
Late 14.27 4.313 9.00 – 31.0 
All Participants 14.12 3.995 9.00 – 31.0 
BAARS-IV Current 
Hyperactivity Subscale 
Score 
(maximum score = 20) 
Early 7.672 2.055 5.00 – 14.0 
On-time 7.080 2.062 5.00 – 14.0 
Late 7.733 2.503 5.00 – 17.0 
All Participants 7.387 2.187 5.00 – 17.0 
 
BAARS-IV Current 
Impulsivity Subscale Score 
(maximum score = 16) 
Early 5.781 2.027 4.00 – 12.0 
On-time 5.606 1.691 4.00 – 14.0 
Late 5.950 2.086 4.00 – 14.0 
All Participants 5.730 1.877 4.00 – 14.0 
BAARS-IV Current 
Sluggish Cognitive Tempo 
Subscale Score 
(maximum score = 36) 
 
Early 17.44 5.363 9.00 – 32.0 
On-time 16.72 4.547 9.00 – 30.0 
Late 17.23 5.261 9.00 – 33.0 
All Participants 17.03 4.929 9.00 – 33.0 
BDEFS Total Score 
(maximum score = 356) 
Early 154.84 38.17 97.9 – 268.0 
On-time 145.10 32.41 91.0 – 273.0 
Late 150.61 34.83 94.0 – 214.9 
All Participants 148.90 34.64 91.0 – 273.0 
BDEFS Self-Management 
to Time Subscale Score 
(maximum score = 84) 
Early 40.52 12.89 21.0 – 74.0 
On-time 37.88 10.63 21.0 – 72.0 
Late 40.77 11.39 24.0 – 68.0 
All Participants 39.08 11.60 21.0 – 74.0 
BDEFS Self-
Organization/Problem 
Solving Subscale Score 
(maximum score = 96) 
 
Early 41.69 13.59 25.0 – 94.0 
On-time 40.04 11.32 24.0 – 81.0 
Late 40.77 11.39 24.0 – 68.0 
All Participants 40.64 11.92 24.0 – 94.0 
BDEFS Self-Restraint 
Subscale Score 
(maximum score = 76) 
Early 30.29 7.128 19.0 – 50.0 
On-time 28.43 6.300 19.0 – 48.0 
Late 28.53 6.749 19.0 – 48.0 
All Participants 28.93 6.648 19.0 – 50.0 
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BDEFS Self-Motivation 
Subscale Score 
(maximum score = 48) 
Early 18.23 5.349 11.9 – 39.0 
On-time 17.23 4.694 12.0 – 37.0 
Late 17.68 4.070 12.0 – 28.0 
All Participants 17.59 4.733 12.0 – 39.0 
BDEFS Self-Regulation of 
Emotion Subscale Score 
(maximum score = 52) 
Early 24.11 8.169 13.0 – 47.0 
On-time 21.52 6.280 13.0 – 43.4 
Late 23.53 7.761 13.0 – 42.0 
All Participants 22.66 7.232 13.0 – 47.0 
DERS Total Score 
(maximum score = 180) 
Early 85.02 22.86 46.0 – 153.0 
On-time 79.13 20.35 39.0 – 146.0 
Late 84.05 23.94 41.0 – 142.0 
All Participants 81.80 21.98 39.0 – 153.0 
DERS Nonacceptance of 
Emotional Responses 
Subscale Score 
(maximum score = 30) 
Early 13.25 5.798 6.00 – 30.0 
On-time 13.06 5.269 6.00 – 29.0 
Late 13.80 5.967 5.06 – 30.0 
All Participants 13.29 5.564 5.06 – 30.0 
DERS Difficulties 
Engaging in Goal-Directed 
Behaviour Subscale Score 
(maximum score = 25) 
Early 16.22 4.971 5.00 – 25.0 
On-time 15.49 5.315 5.00 – 25.0 
Late 16.08 4.906 6.00 – 25.0 
All Participants 15.82 5.125 5.00 – 25.0 
DERS Impulse Control 
Difficulties Subscale Score 
(maximum score = 30) 
Early 12.00 5.401 6.00 – 28.0 
On-time 10.50 4.150 6.00 – 28.0 
Late 11.60 5.578 6.00 – 28.0 
All Participants 11.14 4.881 6.00 – 28.0 
DERS Lack of Emotional 
Awareness Subscale Score 
(maximum score = 30) 
Early 14.45 4.731 6.00 – 25.0 
On-time 13.26 4.405 6.00 – 30.0 
Late 13.81 4.882 6.00 – 26.0 
All Participants 13.70 4.614 6.00 – 30.0 
DERS Limited Access to 
Emotion Regulation 
Strategies Subscale Score 
(maximum score = 40) 
 
Early 18.38 7.704 8.00 – 36.0 
On-time 16.57 6.286 8.00 – 35.0 
Late 17.81 6.664 8.00 – 31.0 
All Participants 17.33 6.781 8.00 – 36.0 
DERS Lack of Emotional 
Clarity Subscale Score 
(maximum score = 25) 
Early 10.72 3.627 6.00 – 21.0 
On-time 10.24 3.394 5.00 – 19.0 
Late 10.94 3.880 5.00 – 25.0 
All Participants 10.53 3.573 5.00 – 25.0 
BFIS Mean Impairment 
Score  
(maximum score = 9) 
Early 2.408 1.867 0.00 – 6.90 
On-time 1.860 1.393 0.00 – 7.08 
Late 2.158 1.589 0.00 – 7.69 
All Participants 2.071 1.583 0.00 – 7.69 
 
RTBQ Total Score 
(maximum score = 99) 
Early 16.61 9.757 1.00 – 42.0 
On-time 13.76 8.635 0.00 – 42.0 
Late 14.39 9.386 0.00 – 42.0 
All Participants 14.63 9.144 0.00 – 44.0 
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Table 2 
Regression Coefficients for Model Variables: BAARS-IV Current Symptoms 
 B (SE) Wald df P 95% CI for Odds Ratio Lower Odds Ratio Upper 
Inattention Score 0.073 (.039) 3.541 1 0.060 0.997 1.076 1.162 
Constant -1.729 (.580) 8.871 1 0.003    
Note. R2 = 0.940 (Hosmer & Lemeshow), 0.019 (Cox & Snell), 0.026 (Nagelkerke). 
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Table 3 
Regression Coefficients for Model Variables: BAARS-IV Current Symptom Counts 
 B (SE) Wald df P 95% CI for Odds Ratio Lower Odds Ratio Upper 
Inattention 
Symptom      
Count 
0.239 (.102) 5.492 1 0.019 1.040 1.270 1.552 
Constant -0.911 (.185) 24.309 1 0.000    
Note. R2 = 0.496 (Hosmer & Lemeshow), 0.029 (Cox & Snell), 0.040 (Nagelkerke). 
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Table 4 
Regression Coefficients for Model Variables: Barkley’s Deficits in Executive Functioning 
Scale 
 
 B (SE) Wald df P 95% CI for Odds Ratio Lower Odds Ratio Upper 
Self-Regulation of 
Emotion Score 0.051 (.022) 5.569 1 0.018 1.009 1.053 1.099 
Constant -1.856 (.526) 12.448 1 0.000    
Note. R2 = 0.091 (Hosmer & Lemeshow), 0.026 (Cox & Snell), 0.036 (Nagelkerke). 
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Table 5 
Regression Coefficients for Model Variables: Barkley’s Deficits in Executive Functioning 
Scale – Symptom Count 
 
 B (SE) Wald df P 95% CI for Odds Ratio Lower Odds Ratio Upper 
Executive 
Function 
Symptom Count 
0.025 (.012) 4.602 1 0.032 1.002 1.026 1.050 
Constant -1.013 (.221) 21.038 1 0.000    
Note. R2 = 0.163 (Hosmer & Lemeshow), 0.024 (Cox & Snell), 0.033 (Nagelkerke). 
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Table 6 
Regression Coefficients for Model Variables: Difficulties in Emotion Regulation Scale 
 B (SE) Wald df P 95% CI for Odds Ratio Lower Odds Ratio Upper 
Impulse Score 0.068 (.033) 4.313 1 0.038 1.004 1.070 1.141 
Constant -1.444 (.402) 12.939 1 0.000    
Note. R2 = 0.344 (Hosmer & Lemeshow), 0.023 (Cox & Snell), 0.031 (Nagelkerke). 
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Table 7 
Regression Coefficients for Model Variables: Total Scores (Backward entry) 
 B (SE) Wald df P 95% CI for Odds Ratio Lower Odds Ratio Upper 
BFIS Total Score 0.191 (.100) 3.657 1 0.056 0.995 1.210 1.472 
RTBQ Total Score 0.029 (.017) 2.852 1 0.091 0.995 1.030 1.065 
Constant -1.565 (.362) 18.711 1 0.000    
Note. R2 = 0.138 (Hosmer & Lemeshow), 0.040 (Cox & Snell), 0.056 (Nagelkerke). 
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Table 8 
Regression Coefficients for Model Variables: Total Scores (Forward entry) 
 B (SE) Wald df P 95% CI for Odds Ratio Lower Odds Ratio Upper 
BFIS Total Score 0.214 (.098) 4.776 1 0.026 1.022 1.239 1.502 
Constant -1.171 (.265) 19.459 1 0.000    
Note. R2 = 0.568 (Hosmer & Lemeshow), 0.025 (Cox & Snell), 0.035 (Nagelkerke). 
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Table 9 
Regression Coefficients for Model Variables: Total Scores – Symptom Counts 
 B (SE) Wald df P 95% CI for Odds Ratio Lower Odds Ratio Upper 
BAARS-IV 
Current Total 
Symptom Count 
0.167 (.068) 6.006 1 0.014 1.034 1.182 1.351 
Constant -0.984 (.199) 24.339 1 0.000    
Note. R2 = 0.058 (Hosmer & Lemeshow), 0.033 (Cox & Snell), 0.046 (Nagelkerke). 
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APPENDICES 
 
APPENDIX A 
 
Demographic Information 
 
Participant’s Name:            
 
Participant’s Student Number:    _____  Current Year:     Major: ___________ 
 
Home Address:             
 
Home Phone:        
 
Cell Phone:        
 
Email:         
 
Name/phone number for another person who will know how to find you if we cannot 
reach you: 
             
 
May we contact you again in the future for other studies? YES  _______  NO ______ 
 
Instructions:  The items in this questionnaire address issues pertaining to your personal 
identity, medical history, and family background. For questions that include numbered 
choice options, please circle the number(s) that best describes your answer.  Other items 
will provide you with space(s) to provide a written response.  Be sure to read each item 
carefully, and direct any questions to a member of the research staff.  Please try to 
answer each item as best you can, however, if you feel uncomfortable with any question, 
you do not need to answer it.  Please know that your answers will be kept completely 
confidential. Please do not write your name on any page but this front page. (This cover 
page will be detached and stored with your consent forms to protect your 
confidentiality.) 
 
 
(FOR PROJECT USE ONLY – ID # ________________________) 
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(PROJECT USE ONLY – ID # _________________)  
 
 
1. DEMOGRAPHIC INFORMATION 
  
Date of Birth (MM/YY): ___/___    Today’s Date (DD/MM/YY):  ___/___/___ 
Age ______ 
 
Race/ethnic background: (please circle) 
[1] ABORIGINAL    
[2] ASIAN OR ASIAN DESCENT    
[3] HISPANIC/LATINO    
[4] NON-HISPANIC BLACK OR AFRICAN DESCENT   
[5] NON-HISPANIC WHITE OR CAUCASIAN  
[6] OTHER/MIXED (please describe)      
[7] PREFER NOT TO ANSWER 
 
Marital status: (please circle) 
[1] SINGLE    
[2] IN A ROMANTIC RELATIONSHIP  
[3] MARRIED/CIVIL UNION/COHABITING 
[4] WIDOWED 
[5] PREFER NOT TO ANSWER 
 
Body Weight: ___________ (POUNDS (lb) / KILOGRAMS (kg)) 
           (please circle one) 
Height: ___________  
 
Days since last menstrual periods: _______ days 
Typical length of menstrual period: ______ days 
 
Are you currently pregnant? (please circle)    [1] NO     [2] YES   
Is there a chance you could be pregnant? (please circle)    [1] NO     [2] YES   
 
Do you write with your right or left hand? (please circle) 
[1] RIGHT                   [2] LEFT                   [3] BOTH 
Are you employed? (please circle)  [1] NO     [2] YES   
 
IF YES, what is your job title ________________________________________ 
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(PROJECT USE ONLY – ID # _________________)  
 
2. HOUSEHOLD INFORMATION/FAMILY INFORMATION 
 
Total number of household members (including you): _______ 
 
 # of children (under 18 years of age): _______   # of adults: _______ 
 
Parent Information: 
PARENT 
 
RELATION TO 
YOU 
Please indicate if 
BIOLOGICAL, STEP, 
FOSTER, OR 
ADOPTIVE 
AGE OCCUPATION 
HIGHEST 
GRADE 
COMPLETED 
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
Did your mother have any miscarriages?  [1] NO   [2] YES   
 IF YES, how many ________ and the sex (if known): ____ MALE ___ FEMALE 
                           (indicate number) 
Sibling Information 
SEX AGE 
RELATION TO YOU 
If not FULL siblings indicate relatedness: FULL, STEP, HALF, 
ADOPTIVE 
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(PROJECT USE ONLY – ID # _________________) 
3. MEDICAL HISTORY 
Were you ever diagnosed with ADHD or did you ever take a stimulant medication, such 
as Ritalin? (please circle)  [1] NO     [2] YES   
 
Are you currently taking medicine prescribed for ADHD? (please circle) [1] NO [2] YES   
 
Have you ever had any kind of head injury? (please circle)  [1] NO      [2] YES   
IF YES, what happened ______________________________________________ 
IF YES, was there a loss of consciousness? (please circle)  [1] NO     [2] YES   
IF YES, for how long (in hours)?  ____________  
 
Have you ever had a seizure? (please circle)  [1] NO      [2] YES   
 IF YES, specify type: 
[1] FEBRILE, specify # of times ______    
[2] PETIT MAL/ABSENCE, specify # of times _____    
[3] GRAND MAL/TONIC-CLONIC, specify # of times _____    
[4] OTHER, please specify type _________________ and # of times ______  
IF YES, were you ever medicated for seizures? (please circle)  [1] NO     [2] YES   
        Specify when and type of medication:________________________________ 
 
Have you ever been diagnosed with a learning disorder?  [1] NO     [2] YES   
 IF YES, please specify what kind ______________________________________ 
 
Have you ever been diagnosed with any mental disorder? [1] NO     [2] YES 
 IF YES, please specify what kind ______________________________________ 
   
Are you currently taking any form of medication (except as indicated above)?  
            [1] NO   [2] YES  IF YES, please specify what kind _______________________ 
 
4. DEVELOPMENTAL HISTORY 
Has anyone ever told you that you: 
 Started talking late?      [1] NO     [2] YES   
 Crawled or walked late?    [1] NO     [2] YES   
 Were difficult to manage as a young child?       [1] NO     [2] YES   
 Were late in being toilet trained?   [1] NO     [2] YES   
 Had problems getting along with other children? [1] NO     [2] YES   
 Were aggressive toward others?   [1] NO     [2] YES   
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(PROJECT USE ONLY – ID # _________________) 
5. ACADEMIC HISTORY 
Current Year? ________________  Major? _____________________________ 
Current CGPA? ________________ 
Do you like school?    [1] NO     [2] YES 
Are you having any difficulty in school?   [1] NO     [2] YES  
 IF YES, please describe 
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
Do you receive any special services at school?  [1] NO     [2] YES   
 If YES, please specify 
__________________________________________________________________
__________________________________________________________________ 
 
 
THANK YOU FOR TAKING THE TIME TO COMPLETE THIS 
QUESTIONNAIRE !! 
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APPENDIX B 
 
Pubertal Development Scale (PDS) - Women 
Retrospective Version 
7/28/04 CS, JZ, KK 
 
 Women show a large range of ages during which pubertal growth and 
development occur.  We are interested in learning more about this range of individual 
differences in pubertal development.  We ask you to help us get this information by 
answering some questions about what you remember about your own pubertal 
development. 
 When you are answering these questions, it is important to remember that no one 
will see your answers other than the researchers doing this study, and that your name will 
not be listed with your responses (just your identification number will be).  Therefore, 
please be as honest as possible since your honest answers will help us learn about 
variability in these measures. 
 For many questions, we will ask you to estimate the age at which an event 
occurred.  Many people find it useful to think about other events that were occurring 
around the same time to help them remember their age.  For example, you may remember 
that an event occurred in the fourth grade, but not immediately recall the age.  In these 
cases, you may be able to estimate your age based on these other memories and the grade 
you were in at the time.  For additional assistance throughout this questionnaire, please 
also use the “grade level: age” conversion chart provided below. 
Grade Level: Age Conversion Chart 
Grade 1: 6 years old  
Grade 2: 7 years old  
Grade 3: 8 years old  
Grade 4: 9 years old  
Grade 5: 10 years old  
Grade 6: 11 years old  
Grade 7: 12 years old  
Grade 8: 13 years old  
Grade 9: 14 years old  
Grade 10: 15 years old  
Grade 11: 16 years old  
Grade 12: 17 years old  
 
Please remember to read the directions and each question carefully. 
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Section I:  In the following section, please pick the answer that best fits your 
developmental profile.   Please choose only ONE answer for each question. 
 
(1) In general, do you think your development was any earlier or later than most other    
girls?  
1. much earlier 
2. somewhat earlier 
3. about the same 
4. somewhat later 
5. much later 
6. don’t know 
 
(2) Do you think your first period was any earlier or later than most other girls?   
1. much earlier 
2. somewhat earlier 
3. about the same 
4. somewhat later 
5. much later 
6. don’t know 
 
(3) Do you remember the approximate age or grade at which you first menstruated? 
1. yes 
2. no 
 
If you answered “yes”: 
 
(4) How old were you when you had your first period? 
a) ______ years and ______ months old 
b) don’t know 
 
(5) What grade were you in when you had your first period? 
a) ______ grade  
b) don’t know 
 
(6) Do you think your breasts developed any earlier or later than most other girls?  
1. much earlier 
2. somewhat earlier 
3. about the same 
4. somewhat later 
5. much later 
6. don’t know 
 
(7) Do you remember the approximate age or grade in which you first noticed changes in 
your breasts or breast development? 
1. yes 
2. no 
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If you answered “yes”:  
 
(8) How old were you when you first noticed breast development? 
a)  ______ years and ______ months old 
b) don’t know 
 
(9) What grade were you in when you first noticed breast development? 
a)  ______ grade  
b) don’t know 
 
(10) Do you remember the approximate age or grade in which you wore your first  
training bra? 
1. yes 
2. no 
 
If you answered “yes”:  
 
(11) How old were you when you wore your first training bra? 
a)  ______ years and ______ months old 
b) don’t know 
 
(12) What grade were you in when you wore your first training bra? 
a)  ______ grade  
b) don’t know 
 
(13) Both girls and boys go through a growth spurt before puberty, during which time  
         they rapidly increase in height, outgrowing their shoes and clothes. Would you say     
         that your growth in height was any earlier or later than other girls? 
1. much earlier 
2. somewhat earlier 
3. about the same 
4. somewhat later 
5. much later 
6. don’t know 
 
(14) Do you remember the approximate age or grade at which you went through a  
        growth spurt? 
1. yes 
2. no 
 
If you answered “yes”: 
(15) How old were you when you went through a growth spurt? 
a)  ______ years and ______ months old 
b) don’t know 
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(16) What grade were you in when you went through a growth spurt? 
a)  ______ grade  
b) don’t know 
 
(17) Body hair (“body hair” meaning underarm and pubic hair) also begins to grow  
        during puberty.  Would you say that your growth of body hair was any earlier or  
        later than other girls? 
1. much earlier 
2. somewhat earlier 
3. about the same 
4. somewhat later 
5. much later 
6. don’t know 
 
(18) Do you remember the approximate age or grade at which you began to grow body  
        hair? 
1. yes 
2. no 
 
If you answered “yes”:  
 
(19) How old were you when you began to grow body hair? 
a)  ______ years and ______ months old 
b) don’t know 
(20) What grade were you in when you began to grow body hair? 
a)  ______ grade  
b) don’t know 
(21) Hormonal changes during puberty can dramatically change the chemistry of the  
        facial skin, causing pimples and acne.  Would you say your skin changed any  
        earlier or later than other girls? 
1. much earlier 
2. somewhat earlier 
3. about the same 
4. somewhat later 
5. much later 
6. don’t know 
 
(22) Do you remember the approximate age and grade in which your skin started      
       changing?  
1. yes 
2. no 
 
If you answered “yes”: 
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(23) How old were you when your skin started to change? 
a)  ______ years and ______ months old 
b) don’t know 
 
(24) What grade were you in when your skin started to change? 
a)  ______ grade  
b) don’t know 
 
(25) Birth control pills and other types of hormonal contraceptives (e.g., Depo-Provera)  
        are prescribed by doctors prior to the age of 18 for a variety of reasons, including   
        but not limited to acne, irregular menstrual cycles, and as a form of pregnancy  
        prevention.  Are you currently taking hormonal contraceptives? 
1. yes (specify brand, if known):     
2. no 
 
(Did you take any of these types of hormonal contraceptives before the age of 18? 
1. yes 
2. no 
3. don’t know 
 
If you answered “yes,” please answer the following questions: 
  
Hormonal contraceptive(s) taken: 
___ birth control pills (specify brand, if known):     
___ birth control injections (e.g. Depo-Provera, specify type if known):   
  other (specify):     
 
Age start:  I was ______ years and ______ months old when I began taking hormonal 
contraceptives. 
 
Grade start: I was in the ____ grade when I began taking hormonal contraceptives. 
 
Between the start age and the age of 18, did you take hormonal contraceptives?  
3. continuously 
4. stopped and started (had more than one period of use) 
5. stopped after a single period of use 
 
If you stopped after a single period of use, what age were you when you stopped 
taking hormonal contraceptives? 
 
Age:  I was ______ years and ______ months old when I stopped taking hormonal 
contraceptives. 
 
      Grade: I was in the ____ grade when I stopped taking hormonal contraceptives. 
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APPENDIX C 
 
BAARS-IV: Self Report - Current 
Instructions 
 
For the first 27 items, please circle the number next to each item below that best 
describes your behavior DURING THE PAST 6 MONTHS. Then answer the remaining 
three questions.  
 
 
	  
Never 
or  
rarely 
 
Some- 
times 
 
 
Often 
 
Very 
often 
1. Fail to give close attention to details or make 
careless mistakes in my work or other activities 1 2 3 4 
2. Difficulty sustaining my attention in tasks or fun 
activities 1 2 3 4 
3. Don’t listen when spoken to directly 1 2 3 4 
4. Don’t follow through on  instructions and fail to 
finish work or chores 1 2 3 4 
5. Have difficulty organizing tasks and activities 1 2 3 4 
6. Avoid, dislike, or am reluctant to engage in tasks 
that require sustained mental effort 1 2 3 4 
7. Lose things necessary for tasks or activities 1 2 3 4 
8. Easily distracted by extraneous stimuli or 
irrelevant thoughts 1 2 3 4 
9. Forgetful in daily activities 1 2 3 4 
10. Fidget with hands or feet or squirm in seat 1 2 3 4 
11. Leave my seat in classrooms or in other 
situations in which remaining seated is expected 1 2 3 4 
12. Shift around excessively or feel restless or 
hemmed in 1 2 3 4 
13. Have difficulty engaging in leisure activities 
quietly (feel uncomfortable, or am loud or noisy) 1 2 3 4 
14. I am “on the go” or act as if “driven by a motor” 
(or I feel like I have to be busy or always doing 
something) 
1 2 3 4 
15. Talk excessively (in social situations) 1 2 3 4 
16. Blurt out answers before questions have been 
completed, complete others’ sentences, or jump 
the gun 
1 2 3 4 
17. Have difficulty awaiting my turn 1 2 3 4 
18. Interrupt or intrude on others (butt into 
conversations or activities without permission or 
take over what others are doing) 
1 2 3 4 
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Never 
or  
rarely 
 
Some- 
times 
 
 
Often 
 
Very 
often 
19. Prone to daydreaming when I should be 
concentrating on something or working 1 2 3 4 
20. Have trouble staying alert or awake in boring 
situations 1 2 3 4 
21. Easily confused 1 2 3 4 
22. Easily bored 1 2 3 4 
23. Spacey or “in a fog” 1 2 3 4 
24. Lethargic, more tired than others 1 2 3 4 
25. Underactive or have less energy than others 1 2 3 4 
26. Slow moving 1 2 3 4 
27. I don’t seem to process information as quickly 
or as accurately as others 1 2 3 4 
 
28. Did you experience any of these 27 symptoms at least “Often” or more frequently 
(Did you circle a  3 or a 4 above)?        No         Yes     (Circle one) 
 
29. If so, how old were you when those symptoms began? (Fill in the blank) 
I was ______________ years old. 
30. If so, in which of these settings did those symptoms impair your functioning? Place a 
check mark (√) next to all the areas that apply to you. 
 
______ School 
 
______ Home 
 
______ Work 
 
______ Social Relationships 
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APPENDIX D 
 
BDEFS-LS: Self Report 
Instructions 
 
How often do you experience each of these problems? Please circle the number next to 
each item that best describes your behavior DURING THE PAST 6 MONTHS.  
 
 
	  
Never 
or  
rarely 
 
Some- 
times 
 
 
Often 
 
Very 
often 
1. Procrastinate or put off doing things until the 
last minute 1 2 3 4 
2. Poor sense of time 1 2 3 4 
3. Waste or mismanage my time 1 2 3 4 
4. Not prepared on time for work or assigned tasks 1 2 3 4 
5. Fail to meet deadlines for assignments 1 2 3 4 
6. Have trouble planning ahead or preparing for 
upcoming events 1 2 3 4 
7. Forget to do things I am supposed to do 1 2 3 4 
8. Can’t seem to accomplish the goals I set for 
myself 1 2 3 4 
9. Late for work or scheduled appointments 1 2 3 4 
10. Can’t seem to hold in mind things I need to 
remember to do 1 2 3 4 
11. Can’t seem to get things done unless there is an 
immediate deadline 1 2 3 4 
12. Have difficulty judging how much time it will 
take to do something or get somewhere 1 2 3 4 
13. Have trouble motivating myself to start work 1 2 3 4 
14. Have difficulty motivating myself to stick with 
my work and get it done 1 2 3 4 
15. Not motivated to prepare in advance for things I 
know I am supposed to do 1 2 3 4 
16. Have trouble completing one activity before 
starting into a new one 1 2 3 4 
17. Have trouble doing what I tell myself to do 1 2 3 4 
18. Difficulties following through on promises or 
commitments I may make to others 1 2 3 4 
19. Lack self-discipline 1 2 3 4 
20. Have difficulty arranging or doing my work by 
its priority or importance; can’t “prioritize” well 1 2 3 4 
21. Find it hard to get started or get going on things 
I need to get done 
 
1 2 3 4 
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 Never 
or  
rarely 
 
Some- 
times 
 
 
Often 
 
Very 
often 
22. I do not seem to anticipate the future as much or 
as well as others 1 2 3 4 
23. Can’t seem to remember what I previously heard  
      or read about 1 2 3 4 
24. I have trouble organizing my thoughts 1 2 3 4 
25. When I am shown something complicated to do, 
I cannot keep the information in mind so as to 
imitate or do it correctly 
1 2 3 4 
26. I have trouble considering various options for 
doing things and weighing their consequences 1 2 3 4 
27. Have difficulties saying what I want to say 1 2 3 4 
28. Unable to come up with or invent as many 
solutions to problems as others seem to do 1 2 3 4 
29. Find myself at a loss for words when I want to 
explain something to others 1 2 3 4 
30. Have trouble putting my thoughts down in 
writing as well or as quickly as others 1 2 3 4 
31. Feel I am not as creative or inventive as others 
of my level of intelligence 1 2 3 4 
32. In trying to accomplish goals or assignments, I 
find I am not able to think of as many ways of 
doing things as others 
1 2 3 4 
33. Have trouble learning new or complex activities 
as well as others 1 2 3 4 
34. Have difficulty explaining things in their proper 
order or sequence 1 2 3 4 
35. Can’t seem to get to the point of my 
explanations as well as others 1 2 3 4 
36. Have trouble doing things in their proper order 
or sequence 1 2 3 4 
37. Unable to “think on my feet” or respond as 
effectively as others to unexpected events 1 2 3 4 
38. I am slower than others at solving problems I 
encounter in my daily life 1 2 3 4 
39. Easily distracted by irrelevant events or thoughts 
when I must concentrate on something 1 2 3 4 
40. Not able to comprehend what I read as well as I 
should be able to do; have to reread material to 
get its meaning 
1 2 3 4 
41. Cannot focus my attention on tasks or work as 
well as others 1 2 3 4 
42. Easily confused 
 1 2 3 4 
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 Never 
or  
rarely 
 
Some- 
times 
 
 
Often 
 
Very 
often 
43. Can’t seem to sustain my concentration on 
reading, paperwork, lectures, or work 1 2 3 4 
 
44.  Find it hard to focus on what is important from 
what  
       is not important when I do things	  
1 2 3 4 
44. I don’t seem to process information as quickly or 
as accurately as others 1 2 3 4 
45. Find it difficult to tolerate waiting; impatient 1 2 3 4 
46. Make decisions impulsively 1 2 3 4 
47. Unable to inhibit my reactions or responses to 
events or others 1 2 3 4 
48. Have difficulty stopping  my activities or 
behaviour when I should do so 1 2 3 4 
49. Have difficulty changing my behaviour when I 
am given feedback about my mistakes 1 2 3 4 
50. Make impulsive comments to others 1 2 3 4 
51. Likely to do things without considering the 
consequences for doing them 1 2 3 4 
52. Change my plans at the last minute on a whim or 
last minute impulse 1 2 3 4 
53. Fail to consider past relevant events or past 
personal experiences before responding to 
situations (I act without thinking) 
1 2 3 4 
54. Not aware of things I say or do 1 2 3 4 
55. Have difficulty being objective about things that 
affect me 1 2 3 4 
56. Find it hard to take other people’s perspectives 
about a problem or situation 1 2 3 4 
57. Don’t think about or talk things over with myself 
before doing something 1 2 3 4 
58. Trouble following the rules in a situation 1 2 3 4 
59. More likely to drive a motor vehicle much faster 
than others (Excessive speeding) 1 2 3 4 
60. Have a low tolerance for frustrating situations 1 2 3 4 
61. Cannot inhibit my emotions as well as others 1 2 3 4 
62. I don’t look ahead and think about what the 
future outcomes will be before I do something (I 
don’t use my foresight) 
1 2 3 4 
63. I engage in risk taking activities more than others 
are likely to do 1 2 3 4 
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Never 
or  
rarely 
 
Some- 
times 
 
 
Often 
 
Very 
often 
64. Likely to take short cuts in my work and not do 
all I am supposed to do 1 2 3 4 
65. Likely to skip out on work early if my work is 
boring to do 1 2 3 4 
66. Do not put as much effort into my work as I 
should or than others are able to do 1 2 3 4 
67. Others tell me I am lazy or unmotivated 1 2 3 4 
68. Have to depend on others to help me get my work 
done 1 2 3 4 
69. Things must have an immediate payoff for me or 
I do not seem to get them done 1 2 3 4 
70. Have difficulty resisting the urge to do 
something fun or more interesting when I am 
supposed to be working 
1 2 3 4 
71. Inconsistent in the quality or quantity of my 
work performance 1 2 3 4 
72. Unable to work as well as others without 
supervision or frequent instruction 1 2 3 4 
73. I do not have the willpower or determination 
that others seem to have 1 2 3 4 
74. I am not able to work toward longer term or 
delayed rewards as well as others 1 2 3 4 
75. I cannot resist doing things that produce 
immediate rewards even if they are not good for 
me in the long run 
1 2 3 4 
76. Quick to become angry or become upset 1 2 3 4 
77. Overreact emotionally 1 2 3 4 
78. Easily excitable 1 2 3 4 
79. Unable to inhibit showing strong negative or 
positive emotions 1 2 3 4 
80. Have trouble calming myself down when once I 
am emotionally upset 1 2 3 4 
81. Cannot seem to regain emotional control and 
become more reasonable once I am emotional 1 2 3 4 
82. Cannot seem to distract myself away from 
whatever is upsetting me emotionally to help me 
calm me down. I can’t refocus my mind to a 
more positive framework. 
1 2 3 4 
83. Unable to manage my emotions in order to 
accomplish my goals successfully or get along 
well with others 
1 2 3 4 
84. I remain emotional or upset longer than others 1 2 3 4 
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Never 
or  
rarely 
 
Some- 
times 
 
 
Often 
 
Very 
often 
85. I find it difficult to walk away from emotionally 
upsetting encounters with others or leave 
situations in which I have become very 
emotional  
1 2 3 4 
86. I cannot rechannel or redirect my emotions into 
more positive ways or outlets when I get upset 1 2 3 4 
87. I am not able to evaluate an emotionally 
upsetting event more objectively 1 2 3 4 
88. I cannot redefine negative events into more 
positive viewpoints when I feel strong emotions 1 2 3 4 
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APPENDIX E 
 
DERS 
 
Please indicate how often the following statements apply to you by writing the 
appropriate number from the scale below on the line beside each item: 
________________________________________________________________________  
       1-------------------2------------------------3------------------------4-----------------------5  
almost never      sometimes         about half the time       most of the time   almost always  
  (0-10%)       (11-35%)               (36-65%)             (66-90%)     (91-100%)  
______ 1) I am clear about my feelings.  
______ 2) I pay attention to how I feel.  
______ 3) I experience my emotions as overwhelming and out of control.  
______ 4) I have no idea how I am feeling.  
______ 5) I have difficulty making sense out of my feelings.  
______ 6) I am attentive to my feelings.  
______ 7) I know exactly how I am feeling.  
______ 8) I care about what I am feeling.  
______ 9) I am confused about how I feel.  
______ 10) When I’m upset, I acknowledge my emotions.  
______ 11) When I’m upset, I become angry with myself for feeling that way.  
______ 12) When I’m upset, I become embarrassed for feeling that way.  
______ 13) When I’m upset, I have difficulty getting work done.  
______ 14) When I’m upset, I become out of control.  
______ 15) When I’m upset, I believe that I will remain that way for a long time.  
______ 16) When I’m upset, I believe that I’ll end up feeling very depressed.  
______ 17) When I’m upset, I believe that my feelings are valid and important.  
______ 18) When I’m upset, I have difficulty focusing on other things.  
______ 19) When I’m upset, I feel out of control.  
______ 20) When I’m upset, I can still get things done.  
______ 21) When I’m upset, I feel ashamed with myself for feeling that way.  
______ 22) When I’m upset, I know that I can find a way to eventually feel better.  
______ 23) When I’m upset, I feel like I am weak.  
______ 24) When I’m upset, I feel like I can remain in control of my behaviors.  
______ 25) When I’m upset, I feel guilty for feeling that way.  
______ 26) When I’m upset, I have difficulty concentrating.  
______ 27) When I’m upset, I have difficulty controlling my behaviors.  
______ 28) When I’m upset, I believe that there is nothing I can do to make myself feel   
better.  
______ 29) When I’m upset, I become irritated with myself for feeling that way.  
______ 30) When I’m upset, I start to feel very bad about myself.  
______ 31) When I’m upset, I believe that wallowing in it is all I can do.  
______ 32) When I’m upset, I lose control over my behaviors.  
______ 33) When I’m upset, I have difficulty thinking about anything else.  
______ 34) When I’m upset, I take time to figure out what I’m really feeling.  
______ 35) When I’m upset, it takes me a long time to feel better.  
______ 36) When I’m upset, my emotions feel overwhelming. 
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APPENDIX F 
 
BFIS-LF: Self Report  
Instructions 
How much difficulty do you have functioning effectively in each of these major life 
activities? That is, to what degree do you see yourself as being impaired in each of these 
life domains? Please circle the number next to each item that best describes your 
difficulties in functioning DURING THE PAST 6 MONTHS. If that situation does not 
apply to you (for instance, you don’t drive a car, don’t have children, don’t live with 
anyone, etc.), please circle the 99 in the last column (under “Does not apply”) 
 
Major Life Activities 
                                                                                                              Does  
Not                                                                                                         not 
at all       Somewhat             Mild              Moderate            Severe    apply 
1. In your home life with 
your immediate 
family 
0 1         2          3         4          5         6         7          8         9       99 
2. In getting chores 
completed at home 
and managing your 
household 
0         1         2          3         4          5         6         7          8         9        99 
3. In your work or 
occupation 0         1         2          3         4          5         6         7          8         9        99 
4. In your social 
interactions with 
strangers and 
acquaintances 
0         1         2          3         4          5         6         7          8         9        99 
5. In your relationships 
with friends 0         1         2          3         4          5         6         7          8         9        99 
6. In your activities in 
the community 
(church, clubs, social 
groups, 
organizations) 
0         1         2          3         4          5         6         7          8         9        99 
7. In any educational 
activities (college, 
night classes, 
technical training, 
occupational 
training). 
0         1         2          3         4          5         6         7          8         9        99 
8. In your marital, co-
living, or dating 
relationships 
0         1         2          3         4          5         6         7          8         9        99 
9. In your management 
of your money, your 
bills, and your debts 
0         1         2          3         4          5         6         7          8         9        99 
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Major Life Activities 
                                                                                                              Does  
 Not                                                                                                        not 
at all       Somewhat             Mild              Moderate            Severe     apply 
10. In driving a motor 
vehicle and in your 
history of citations 
and accidents 
0         1         2          3         4          5         6         7          8         9        99 
11. In your sexual 
activities and sex 
relations with others 
0        1         2          3         4          5         6         7          8         9       99 
12. In your organization 
and management of 
your daily 
responsibilities 
0         1         2          3         4          5         6         7          8         9        99 
13. In caring for yourself 
daily (dressing, 
bathing and hygiene, 
eating, sleeping, etc.) 
0         1         2          3         4          5         6         7          8         9        99 
14. In maintaining your 
health (exercise, 
nutrition, preventive 
medical and dental 
care, etc.) 
0         1         2          3         4          5         6         7          8         9        99 
15. In taking care of and 
raising your children 0         1         2          3         4          5         6         7          8         9        99 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX G 
 
RISK-TAKING BEHAVIOUR QUESTIONNAIRE 
  
 
Please indicate which behaviours you have engaged in over the LAST SIX MONTHS.  
 
 
       N / Y   HOW OFTEN? 
DRIVING 
Have you exceeded the speed limit?  [1] NO    [2] YES     Never   Once     2-5 times     6-10 times    11 or more times 
Have you NOT worn a seatbelt in a moving car? [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you driven without a license?   [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you been a passenger with a drunk driver? [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you ever driven after drinking?   [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
 
DRUGS/ALCOHOL/CIGARETTES 
Have you smoked marijuana?   [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you used cocaine or crack?   [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you used heroine or another illegal opiate? [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you used inhalants (e.g. “huffing”)  [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you used prescription drugs not prescribed by a doctor or that were not prescribed for you? 
       [1] NO    [2] YES  Never   Once     2-5 times  6-10 times  11 or more times 
Have you consumed alcohol?   [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you smoked cigarettes?   [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you used any other illegal drug?  [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
LAW BREAKING 
Have you broken any laws with non-violent behaviour (e.g., shoplifting)? 
[1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you broken any laws with violent behaviour (e.g., assault with or without a weapon)? 
       [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you ever broken probation or other legal agreement? 
[1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
Have you had an interaction with the police that resulted in arrest or detainment? 
       [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
FAMILY RULES BROKEN 
Have you broken any rules set by your family (e.g.., curfew)? 
       [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
SEXUAL BEHAVIOUR 
Have you had sexual intercourse?   [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times  
Have you had oral sex?    [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times  
Have you had anal sex?    [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times  
Have you NOT used a condom or any other barrier method when engaged in sexual activity with a partner? 
       [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times  
Have you been paid for sexual activity?  [1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times  
Have you had sexual activity with more than one person in a 24-hour period? 
[1] NO    [2] YES     Never   Once     2-5 times  6-10 times  11 or more times 
  
Age at first sexual intercourse?  ___________ years   Total life-time number of sexual partners? ____________
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